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INTERACTION BETWEEN MICROPOLLUTANTS AND DEGRADATIVE 
BIOFILM COMMUNITIES: BASIS FOR A BIOMIMETIC APPROACH TO 
WATER TREATMENT 
Master of Science/Magister Scientiae, 2017 
Kirsten Kenchenten 
Department of Microbiology, Stellenbosch University 
Abstract 
The remediation and reclamation of water has become a critically important issue, as the use of water as a 
conduit of waste has resulted in the contamination of a resource that life on Earth cannot function without. 
Research has shown that pollutants at trace levels, or micropollutants, are not being removed adequately from 
treated water and, in some cases, the micropollutant concentrations actually increase following treatment. 
Microbial aggregates, such as biofilms, are important constituent in wastewater treatment, in both 
conventional wastewater treatment plants (WWTPs) and in new-generation alternatives such as biomimicry-
based constructed wetlands. This project was conducted in the paradigm of biomimicry, the concept of using 
inspiration from nature to provide innovative solutions to anthropogenic problems. The aim of the study was 
two-fold; namely 1) to investigate the laboratory-based degradation of selected micropollutants by biofilms, 
with microbial activity as the key driver of biodegradation and, 2) to extrapolate these findings to gain 
understanding of the microbial processes responsible for the functioning of biomimicry-based water 
treatment systems. Of particular interest was the potential consequence of labile nutrient availability on the 
degradation of micropollutants in the treatment systems.  The results showed that, while labile carbon sources 
(such as glucose) do affect the removal of the tested micropollutants, methylparaben and carbamazepine, the 
degree of this effect is not significant enough to explain the lack of micropollutant removal. In contrast, these 
two compounds had a significant effect on biofilm structure, even when applied at low concentrations (1000 
ng.L-1 and 600 ng.L-1 for methylparaben and carbamazepine, respectively), as revealed by scanning confocal 
laser microscopy. Microbial biofilms execute degradative functions with flexibility and are furthermore able 
to efficiently adapt in a manner that humans have yet to replicate. Since our dependency on natural processes 
such as bio-utilisation and bio-assistance of microbes in our constructs cannot be denied or replaced, 
biomimicry shows promise as a framework for the design of wastewater treatment systems that replicate 
natural processes. 
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Opsomming 
 
Die remediëring en herwinning van water het 'n krities belangrike saak geword, as gevolg van water wat 
gebruik word as 'n watervoor vir afval. Dit het gelei na die besoedeling van ‘n hulpbron waarsonder lewe op 
aarde nie kan funksioneer nie. Navorsing het bewys dat besoedeling  in baie klein hoeveelhede as ook 
mikrobesoedeling nie doeltreffend vanuit behandelde water verwyder word nie en in seker gevalle selfs 
verhoog word na behandeling van die water. Mikrobiese aggregate soos biofilms, is 'n belangrike bydrae tot 
afvalwater behandeling in beide tradisionele rioolsuiweringswerke asook in nuwe-generasie alternatiewe 
soos biomimiek-gebaseerde opgerigte vleilande. Hierdie projek was gedoen in die paradigma van biomimiek, 
die konsep om inspirasie vanuit die natuur te verkry om innoverende oplossings te vind vir antropogeniese 
probleme. Die doel van die studie was tweeledig; naamlik 1) om die laboratorium-gebaseerde degradasie van 
geselekteerde mikrobesoedeling te bestudeer deur die gebruik van biofilms met mikrobiese aktiwiteite as die 
sleutel dryfpunt van die biodegradasie, asook die ekstrapolering van hierdie bevindings om kennis te bekom 
van die mikrobiese proses wat verantwoordelik is vir die funksionering van biomimiek-gebaseerde 
waterbehandeling sisteme. Van spesifieke belang was die potensiële gevolg wat labiele voedingstof 
beskikbaarheid op die degradasie van mikrobesoedeling in behandeling sisteme het. Die resultate het gewys 
dat labiele koolstof bronne (bv. glukose) wel 'n bydrae lewer om die getoetsde mikrobesoedeling, 
methylparaben en carbamazepine, te verwyder, maar ook dat dit nie beduidend genoeg was om die tekort van 
mikrobesoedeling te verduidelik nie. In kontras het hierdie twee verbindings het 'n beduidende effek op 
biofilmstrukture gehad, selfs waneer dit in klein konsentrasies (1000 ng.L-1 en 600 ng.L-1 vir methylparaben 
en carbamazepine, onderskeidelik) toegedien was, soos bewys deur middel van 'n skandering konvokale laser 
mikroskopie. Mikrobiese biofilms voer degradering uit met buigsaamheid en is daardeur in staat om aan te 
pas in ‘n manier wat mensdom nog moet naboots. Omdat ons afhanklikheid op natuurlike prosesse soos bio-
benutting en bio-bystand nie ontken of vervang kan word nie, lyk biomimiek belowend as 'n raamwerk vir 
die ontwerp van afvalwaterbehandeling sisteme wat natuurlike prosesse naboots. 
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
Stellenbosch University  https://scholar.sun.ac.za
IX	  
	  
Acknowledgements 
 
I would like to thank my supervisor, Professor Gideon Wolfaardt, for both the opportunity and support during 
the duration of my thesis. I would also like to thank the Water Research Commission (WRC), BiomimicrySA 
and Golder Associates for the financial support. 
 
With respect to the day-to-day laboratory work, I would like to thank Dr Elanna Bester and Edward Archer 
for sharing their knowledge, expertise and experience, and for serving as walls off of which to bounce theories 
and ideas. I would also like to thank all the students and staff in the lab for being great company and for 
making me feel welcome, as a newcomer to Stellenbosch and to the laboratory. I am especially grateful for 
those members of the lab, and within the department, with whom I have made friends and with whom I hope 
to stay in touch. They have made the days brighter and the harder times less tedious. 
 
Last, but not least, I would like to thank my family, friends and all other loved ones for their unfaltering love, 
support and patience during these last two years. Their constant encouragement from such a long distance 
kept me motivated. I owe a large part of my success to them and am humbled by their persistent love and the 
tenacity of their faith in me, even in the most difficult of times. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
"It is our choices, Harry, that show what we truly are, far more than our abilities.” 
                                                                                – J.K. Rowling, Harry Potter and the Chamber of Secrets 
 
	  
Stellenbosch University  https://scholar.sun.ac.za
1	  
	  
Chapter 1: Introduction 
 
Fresh water comprises less than 1% of the total volume of water on Earth, which must be shared by upwards 
of 7 billion humans (Dimick, 2014) as well as every other living organism residing on the planet. This 
implies that water is an extremely scarce resource that needs to support a vast number of individuals in the 
recent future. The manner in which water has been managed thus far is therefore relatively alarming 
considering that our survival is heavily dependent on its’ availability: humans use water as a conduit of 
waste. Since the introduction of aqueducts by the Babylonians (750 B.C.) and thereafter the Romans (312 
B.C.) (AncientHistoryEncylopaedia, 2016), water has been used to transport elimination waste away from 
our homes; to wash our clothes, bodies and various household items. Coupled with this, the sudden and 
vast advances in medical and scientific technology have resulted in the development and production of 
thousands of pharmaceutical drugs, cosmetics and personal care products, which end up in the surface water 
systems. These different substances contain at least one, if not many, chemical compounds that have 
detrimental effects on the health of the environment and the organisms within it, including that of humans 
(Boxall, 2004).  
 
Technology has allowed for the implementation of wastewater treatment (WWT) methods that all aim to 
remove solid and dissolved waste (both organic and inorganic) as well as pathogens, heavy metals and 
some of these abovementioned chemical pollutants, in order to enable the recycling of the once heavily-
sullied and mistreated resource without which life cannot exist. These WWT plants (WWTPs) vary, from 
the conventional sewage treatment plants to the newer, more ecologically-directed, sustainable, eco-
friendly alternatives (constructed wetlands, soil aquifer treatments (SATs), etc.). Despite the variation in 
the detailed design parameters and engineered intricacies of these different WWTPs, the intention for their 
construction remains the same: the adequate treatment of wastewater.  
 
In most countries, access to adequate WWT is something widely taken for granted, but in developing 
countries some communities do not have access to such crucial amenities. In South Africa, for example, 
only those residing within planned residential areas and farm plots have access to indoor plumbing and 
WWT. Many individuals living in rural settlements obtain water from communal taps and dispose of the 
wastewater in makeshift conduits that run the water, untreated, directly (or indirectly) into the surface water 
systems, causing serious pollution. Government intervention is not likely in the near future and therefore 
one of these communities, Langrug in the Franschhoek area of the Western Cape, was chosen to receive an 
Eco-Machine™, designed by John Todd Ecological Design, to treat the wastewater before it enters, and 
contaminates, the Berg River. Essentially this Eco-Machine, also referred to as a “Living Machine”, 
comprises of a series of cells that each contain a variety of plants, animals, microorganisms and associated 
microbial biofilms. The water to be treated runs through these cells, while the organisms within degrade 
the organic and inorganic components to use as an energy source. The construct is biomimetic; as it is based 
on wetland biomes found in nature. More detail regarding the function of these constructed wetlands is 
given in the literature review. 
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Research has shown, especially in the case of conventional WWTPs, that the aforementioned anthropogenic 
chemicals are not completely removed during the wastewater treatment process (Daughton and Ternes, 
1999). In a controlled environment, such as a laboratory, microbial biofilms have been shown to elicit 
degradation or sequestration (bioaccumulation) of these compounds (Bathe et al., 2009), through adaptation 
or recombinant DNA technology. However, the same removal efficiency has not been achieved when these 
microbes were applied to real-life environments or to environments that simulate the actual conditions 
(Goldstein et al., 1985). It is possible that the reason for this lowered removal efficacy is due to the increased 
availability of more labile (energetically-preferred) compounds in the environment. Microbes are energy 
efficient and will not degrade complex pollutants that may require specialised catabolic pathways with 
additional, energy-expensive enzymes when a more energy-efficient nutrient source is available (Snyder 
and Champness, 2007). 
 
1.1) Research Aims and Hypotheses 
 
The first aim of this thesis was the investigation of the competition between labile carbon sources, 
requiring very little energy investment on the part of the microbe, and micropollutants, which are 
relatively more recalcitrant to microbial degradation. This was achieved by constructing a novel 
biomimicry-based biofilm reactor that allows for exposure of a biofilm to a bulk aqueous flow with both 
a labile carbon source and a micropollutant. The intent is to allow depletion of the labile carbon source 
until the biofilm downstream is forced to use the remaining micropollutant as a carbon source. It is 
anticipated that the outcome of this study will guide future studies considering modifications to 
wastewater treatment processes aimed specifically at the removal of these compounds. The hypothesis 
was that the presence of a more labile nutrient would reduce or completely inhibit the degradation of 
the micropollutant. The reasoning behind this postulate was that while the more labile carbon source is 
present, the microbes will use it as a primary carbon and/or energy source simply because it produces a 
high energy output to input ratio. Utilisation of the micropollutant would likely require different 
metabolic pathways than the labile carbon source, and therefore the microbes within the biofilm would 
have to produce a different set of enzymes, requiring the initiation of further anabolic activities (which 
uses energy). Therefore, the utilisation of the micropollutant by the biofilm, in terms of its’ net energy 
yield, would be inefficient relative to the labile source.  
 
The second aim of this research was to ascertain the effects of the selected micropollutants 
(methylparaben and carbamazepine) on microbes, namely the effect on the structure of biofilms and the 
effect on recombinant yeast expressing human endocrine receptors. The effect of micropollutants (at 
environmental levels) was hypothesised to affect the structure of the biofilms but the extent to which 
the effects would be evident was not known. The recombinant yeast served to test the effects of both 
micropollutants on the yeast cell, as well as the effect on the endocrine receptors. Therefore, the purpose 
was two-fold: to test the effects on yeast (potential cytotoxicity) and the potential endocrine-disrupting 
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effects on humans. The hypothesis of this second aim was that methylparaben would show endocrine-
disrupting effects on the receptors, and lethal effects on yeast and pure bacterial cultures, but that there 
would be a low inhibitory effect on the mixed microbial cultures. Carbamazepine was also hypothesised 
to have these same effects. 
 
The final aim was to evaluate the potential of biomimetic constructs, such as constructed wetlands (Eco-
Machines™) for removal of pollutants from wastewater and whether their use is viable in a real-world 
application. The hypothesis is that they will be advantageous in certain situations but that their use would 
be limited, since they are based on an ecosystem, which will always have carrying capacities and 
limitations. 
 
The main aims for this research are summarised as follows: 
1) To investigate the competitive effects of labile carbon sources on the metabolism of two selected 
micropollutants in the presence of degradative biofilms. 
2) To investigate the effects of the selected micropollutants on the structure of biofilms to which 
they are exposed, as well as the endocrine effects of these same micropollutants as determined 
using transgenic yeast expressing human endocrine receptors. 
3) To evaluate the potential of biomimicry in the design of systems for the removal of 
micropollutants from wastewater 
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Chapter 2: Review of Literature 
 
 
2.1) Challenges for Modern Water Treatment Systems  
 
Humans, compared to other species inhabiting the earth, are regarded as the most destructive. Ecosystems 
provide a cyclic, harmonious relationship between organisms, where each organism has a function within 
a niche and contributes to maintaining overall homeostasis. Humans often do not comply with this rule 
of nature, removing natural resources and mostly offering little but unusable, and often toxic, waste 
products. Water is one of these resources. Less than 1% of the water on the surface of the earth is potable 
(Lenntech, 2015; Dimick, 2014).  
 
The advance in modern technologies has allowed for the production and use of a large array of synthetic 
compounds for both medical and non-medical use. Many of these compounds are readily available, are 
used in large quantities, and are prevalent in the water as a consequence. While personal-care products 
(PCPs) are not intended for ingestion, they are topically applied or are used as cleaning agents and are 
therefore washed out talis qualis into grey water. In the case of pharmaceuticals, some of the compounds 
in question are not completely metabolised in the body which, in turn, results in the excretion of un-
metabolised, potentially active drugs (Jjemba, 2006) that eventually end up in the sewage system 
(WWTPs) (Gros et al., 2007; Kasprzyk-Hordern et al., 2009).  
 
Research conducted by Kasprzyk-Hordern et al. (2009) involved the monitoring of rivers in South Wales, 
and revealed that treated effluents from WWTPs were the primary contributor to pharmaceuticals and 
personal-care products (PPCPs) in these rivers. The question that then arises from this information is to 
what degree PPCP accumulation is occurring in the river or surface water systems around the world? The 
next question that arises is why the wastewater treatment processes currently in use are inadequate for 
complete removal of these PPCPs?  
 
There are currently two types of WWTPs in use: conventional WWTPs (in both municipal and industrial 
systems), and treatment systems that are designed with the aim to be more eco-friendly (natural wetland-
based waste-water treatment systems, for example). The former is discussed in detail in this section, while 
the latter is covered in more detail in the section pertaining to biomimicry (section 2.4). Conventional 
treatment of sewage, occurring in conventional WWTPs, begins with transportation of the wastewater 
through the underground sewage system, until it flows into a wastewater treatment plant. Once there, the 
water is processed to remove organic pollutants and pathogenic microbes, and is subsequently returned 
into the surface water system.  
The majority of global conventional WWTPs consist of 3 to 4 processes: preliminary treatment, primary 
treatment, biological treatment and tertiary treatment (Bitton, 1994). Preliminary treatment depends on 
the nature of the incoming sewage, but consists of grit chambers and screens to trap large contaminants 
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or articles of trash (Bitton, 1994). Primary treatment involves primary sedimentation, where both organic 
and inorganic solids (ones that settle) are removed (Pescod, 1992), after which the wastewater goes into 
biological treatment (secondary treatment). This consists of aeration and sedimentation (trickling filters, 
activated sludge, etc). The aeration serves to provide the ideal environment for biodegradation by aerobic 
microorganisms, and the microbes degrade the larger compounds in the sewage into small inorganic 
products, such as ammonia (NH3), water (H2O) and carbon dioxide (CO2) (Pescod, 1992). This stage is 
where the majority of organic contaminants (including pharmaceuticals and personal-care products 
(PPCPs) are removed. The tertiary treatment consists of flocculation, oxidation and adsorption processes 
(Bitton, 1994; Zwiener and Frimmel, 2000), and is an adapted form of secondary treatment. This is the 
step in which the removal of residual constituent contaminants (PPCPs, heavy metals, phosphorus and 
other low concentration contaminants), not removed in secondary treatment, occurs (Pescod, 1992). 
Release of water from the plant into the surface water system occurs after the tertiary treatment. Even 
though PPCPs do undergo some form of metabolism and removal in the WWTP systems, some of them 
have been detected in surface water systems around the world (Gros et al., 2007; Kasprzyk-Hordern et 
al., 2009) and their removal is incomplete (Heberer, 2002). This incomplete removal does not support the 
release of treated effluent water into surface water. The relative concentrations of these substances in both 
influent and effluent water from WWTPs are indicative of not only the types, but also the concentrations 
of PPCPs flowing into and being degraded within these systems. Potential interactions between PPCPs 
may additionally influence removal efficiency in ways that are not well understood.  
 
The following section of the literature review will focus on the significance of increasing population 
density and chemical advancements, due to increasing medical technology, in the direct and indirect 
contamination of water with PPCPs. The associated physiological effects of these PPCPs on non-target 
organisms is also discussed as it is of medical significance for humans, especially where potential effects 
of combined low-dosage and long-term exposure are concerned. Lastly, the current potential of WWTPs 
for the removal of PPCPs is discussed, including a summary of the efficacy of both WWTPs and Eco-
machines in the removal of PPCPs, based on collected research data obtained from the available literature. 
 
2.1.1) Dense Populations and Chemical Advancements 
 
Humans have inhabited the earth for little over 200 000 years, with the emergence of human 
civilisations under 6000 years ago (Howell, 2015) according to the earliest records, dating back to 
Mesopotamia in 3500 B.C. (Seton, 1978; Ascalone and Schultz, 2007) and the Ancient Egyptians in 
3000 B.C. (Grimal, 1992). Humans have come a long way from early roots, and have made remarkable 
advances in technology, science and engineering and, consequently, have successfully ensured 
dominance over the planet. The human population is estimated to be in excess of 7 billion people 
(Dimick, 2014), with each individual producing between 0.3 and 2.0 kg waste/capita/day (UNEP, 
2005), depending on the level of development of the area, with more developed areas resulting in more 
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waste produced per capita per day, and even greater volumes of industrial waste. Also, according to 
research conducted by Kasprzyk-Hordern et al. (2009), the raw sewage collected from the 
municipalities in their study amounted to as much as 10 kg/day of pharmaceuticals and personal-care 
products for the Cilfynydd WWTP alone, which served 111 000 people at the time of publication. This 
is a concerning mass considering the small amounts that are used per person. It is therefore evident 
from the aforementioned information that the need to remove the vast amounts of waste products 
efficiently is significant.  
 
Advances in medicine and science have enabled the production of an enormous array of 
pharmaceutical drugs and potentially toxic chemicals present in detergents, cleaning solutions and 
other personal-care products. In the literature these compounds are collectively grouped and referred 
to as pharmaceuticals and personal-care products (PPCPs) and micropollutants, and will be henceforth 
referred to as the latter. Examples of pharmaceutical drugs used in abundance include those of both an 
acute and chronic nature. The most common drugs for acute usage (taken for the duration of a few 
days to a week) that end up in the water systems include most antibiotics (β-lactam antibiotics, 
macrolides, sulphonamides, etc.), non-steroidal anti-inflammatories (NSAIDs) such as 
acetaminophen, diclofenac, paracetamol, tramadol, etc. and corticosteroids. Chronically-used drugs 
include β-blockers (Petrović et al., 2005), psychiatric drugs such as carbamazepine (Petrović et al., 
2005), fluoxetine and diazepam, angiotensin inhibitors and synthetic hormonal contraceptives (17α-
ethynylestradiol (Aris et al., 2014). In South Africa, drugs used for the treatment of diseases prevalent 
due to lower socioeconomic status are also relatively widespread, including anti-retrovirals for the 
treatment of HIV/Aids, and isoniazid and rifampin for the treatment of extensively drug-resistant 
tuberculosis (XDR TB) (CDC, 2013). These drugs are used for prolonged periods and their presence 
in effluent and surface water systems is therefore arguably more of a concern than that of most acutely-
used drugs (with the exception of antibiotics) since they are used, and therefore excreted, over a longer 
period of time. Examples of common micropollutants (more specifically the aforementioned PCPs, 
rather than pharmaceuticals) include antimicrobial preservatives such as the parabens, other 
antimicrobials such as triclocarban, triclosan and other chemicals such as lauric acid and silicones 
(dimethicone, cyclomethicone, etc.) found in toothpastes, household detergents, shampoos and 
cosmetics (Boxall et al., 2012).  
 
Many of these micropollutants, in their native (unaltered) form, have already been shown to occur in 
surface water systems into which effluent is released (Daughton and Ternes, 1999; Heberer, 2002). 
These compounds remain bioactive and can therefore induce intended, as well as unintended, 
physiological effects on non-target biological organisms after release into the environment. The 
retained naïve chemical structure of these substances indicates that they are still in their intended active 
form and, via logical deduction, may be able to elicit physiological responses in biological systems for 
which the pharmaceutical effects were not intended. Unfortunately, the problem does not end with 
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breaking down these parent compounds into daughter metabolites, as these are not only potentially 
biologically-active but can also reconstitute into their original parent compounds (Gros et al., 2007) 
when the effluent in which they are contained is released into surface water. This reversion was seen 
with 17-α ethynylestradiol (Aris et al., 2014). That being said, producing inactive metabolites, or 
metabolites with less extensive physiological activity than their parent counterparts, provides 
compelling reason to find solutions for the complete mineralization of these parent micropollutants. In 
the case where the micropollutants in question have daughter metabolites with greater biological 
activity than the parent compound, finding a means with which to break down the compound into 
metabolites is only the first step in the solution to removal of micropollutants. The next step would be 
to remove the daughter compounds via further breakdown into biologically inactive metabolites, or 
uptake or sequestration of these compounds by organisms such as bacteria, fungi or plants. 
                
2.1.2) Chemical Loads in Municipal and Environmental Water 
 
The aforementioned presence of micropollutants in surface water systems, into which effluent from 
wastewater treatment plants is released, is indicative of the inadequate, and clearly selective, removal 
of anthropogenic micropollutants. The respective micropollutant removal efficiencies also vary from 
plant to plant, depending on the types of processes applied (Ramirez et al., 2009), the initial levels and 
chemical properties of the water, as well as the chemical properties of the micropollutants themselves. 
The levels of the latter are determined by the usage of micropollutants by the population from whence 
the water is sourced. The relative concentrations of micropollutants in wastewater are of concern with 
systems using microbes for contaminant removal, where the type and relative abundances of certain 
micropollutants result in some being removed with better efficiency than others (Onesios-Barry et al., 
2014). This, in turn, results in preferential removal of some micropollutants over others (as was seen 
in the research by Onesios-Barry et al (2014)), or perhaps not at all in the presence of carbon sources 
that are preferentially metabolised.  
 
Kasprzyk-Hordern et al. (2009) came to the conclusion, from their research in South Wales, that 
effluents from sewage treatment plants are the largest contributors of micropollutants in natural river 
water systems, which in South Wales amounted to 3 kg of micropollutants released per day from the 
Cilfynydd WWTP. This amount is specific to South Wales and doesn’t reflect the mass of 
micropollutants in other localities, but it does provide a sobering figure to the amount of these 
compounds that may be released into natural aquatic systems. As mentioned in the previous section, 
these same authors recorded an approximation of 10 kg of micropollutants per day in influent 
wastewater to the Cilfynydd WWTP. It could therefore be estimated that the WWTPs were responsible 
for the removal of 7 kg of the detected micropollutants. The Cilfynydd WWTP processed between 21 
and 51 million litres in a 24 hour period (Kasprzyk-Hordern et al., 2009), (which means the 
concentration of micropollutants discharges was between 60 and 140 µg.L-1 per day (using a rough 
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calculation based on flow rates of the WWTP). While this degree of removal may seem relatively 
effective, it means that some measure (approximately 3 kg in the case of the aforementioned research) 
of micropollutants, however minimal, are still being released into the environment. Some 
micropollutants are bioactive at low levels (ng.L-1 and µg.L-1) and since many of these compounds 
function at the receptor level, they can potentially still elicit physiological responses in mammals, 
including humans. Not much research has been conducted on the effects of micropollutants on humans 
in vivo due to the ethical limitations involved in this type of experimentation. Some adverse effects 
have been found to occur in mammals, such as rats, and lower level vertebrates, such as fish and 
amphibians. Experiments have also been conducted on human cancer cell lines and yeast expressing 
human receptors, such as the research done by Wróbel and Gregoraszczuk (2014) for the former and 
Routledge and Sumpter, (1996) for the latter. The effects of micropollutants on these types of 
organisms and cell lines are covered in the subsequent section. 
 
The presence and relative abundance of micropollutants in aquatic environments around the world 
would depend on the nature and usage of products in the surrounding areas. The relative levels in 
influent and effluent wastewater in South Africa are shown in Table 2.1. These levels are accompanied 
by values for the U.K., as a comparison. The effluent wastewater values for the micropollutants are 
the values discharged into the surface waters. This data may only apply to specific treatment plants, 
but it gives an indication of the efficiency of WWTPs and the levels of micropollutants being 
discharged into surface waters. Methylparaben is removed with an efficiency of greater than 90%, 
whereas carbamazepine has a relatively low efficiency of removal and even appears to increase in 
concentration when compared to the influent. 
	  
Table 2.1: WWTP (influent vs effluent) concentrations of selected micropollutants  
The data shows micropollutant concentrations in sewage influent and treated sewage effluent from a WWTP 
in both South African (indicated in bold) and international (United Kingdom) (italics) contexts. The removal 
efficiency data and concentration data are reported as is from the given literature. 
	  
A concern is that many studies being conducted on surface water in the environment focus on those 
rivers into which significant volumes of WWTP effluent are released. This may lead to an 
overestimation and inaccurate conclusions on the state of surface waters as a whole, due to the fact 
Micropollutant (Type) 
Concentration of Micropollutant 
in Water Source (ug/L) Removal 
Efficiency (%) Reference Influent of 
WWTP 
Effluent of 
WWTP 
Carbamazepine  
(Anti-Tremorigenic) 0.8      |    0.95 0.7  |   0.83 <10%   |    -24% 
 
(Archer et al., 
2017)  
 
(Kasprzyk-
Hordern et al., 
2009) 
Methylparaben  
(Preservative) 200   |11 601 0.1   |     9 >90%   |  >90% 
Paracetamol  
(NSAID) 178 0.35 >90% 
Diclofenac  
(NSAID) 6        |   0.26 4.5   |    0.18 40-50%|  -33% 
Trimethoprim  
(Antibiotic) 9-10   |      2.9 2      | 0.876 70-80%| >70% 
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that these types of surface waters may show a much higher concentration than would be seen 
downstream where dilution, sequestration, dissipation or further biodegradation of the micropollutants 
may occur. Taking samples from various zones in the river systems would provide a more inclusive, 
and less biased, dataset of contaminant levels. 
 
2.2) Physiological Effects of Micropollutants on Biological Systems 
 
The presence of micropollutants in WWTP effluents released into surface waters has been reported. The 
cause of environmental contamination of micropollutants is thus attributed to inadequate removal during 
treatment (Ternes, 1998; Kasprzyk-Hordern et al., 2009). The significance of this, however, lies in 
whether these micropollutants have deleterious effects on biological organisms that live in/off these water 
sources and, if this is the case, what effects will be seen in higher mammalian organisms in the future. 
Compounds that have the ability of eliciting physiological or pharmacological effects in organisms to 
which the compounds are not native, are referred to as xenobiotics (Studdert et al., 2012; Katzung and 
Trevor, 2015). Based on this definition many, but not all, micropollutants are therefore classified as 
xenobiotics. For the purposes of maintaining clinical relevance, the focus of this research study was 
xenobiotic micropollutants. It is more pertinent that micropollutants, capable of causing any type of 
physiological effect on individuals, for which the compound was not intended, are removed from the 
contaminated source. This is because contaminating micropollutants can potentially elicit physiological 
responses in non-target organisms that are exposed to the aforementioned contaminated source (water, in 
this case). 
 
The number of reports being published regarding the physiological effects of micropollutants in non-
target vertebrates and invertebrates is increasing. Studies have been conducted that investigate effects of 
micropollutants (both pharmaceuticals as well as PCPs) (the specific references are mentioned in this 
chapter). Many micropollutants have been shown to elicit physiological effects on organisms and cell 
lines and, for the purposes of relevance and simplicity, only a few compounds will be discussed in detail. 
These compounds of relevance, used in the experimental portion of this research project, include the 
paraben group (particularly methyl- and propylparaben and psychoactive benzodiazepines (such as 
carbamazepine)), the latter of which is inefficiently removed during conventional treatment processes and 
both of which are not completely removed. Research conducted on the accumulation of micropollutants 
in animal populations exposed to the natural contaminated sources will also be discussed as they are of 
significance in linking the presence of micropollutants in environmental water sources with the adverse 
effects caused in organisms. 
 
The aforementioned deleterious physiological endocrine effects bear no significance if it cannot be shown 
that the same effects occur with environmental concentrations of micropollutants. A study conducted by 
Brooks and colleagues in 2005 was the first published documentation on the accumulation of 
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anthropogenic pharmaceuticals in the liver, muscle and brain tissues of fish in aquatic river environments 
where effluent is known to be released (Brooks et al., 2005; Ramirez et al., 2009). This study however, 
used only post-mortem chemical and histological analyses to show physical accumulation of 
micropollutants and do not show what active effects these compounds had, if any, on living fish. 
Recording accumulation of micropollutants post-mortem in tissues of aquatic animals exposed to 
micropollutant-contaminated effluent water does not illustrate what deleterious effects occur as a result 
of bioaccumulation in the living animal, and therefore an accurate conclusion concerning the threat that 
micropollutants pose in the environment and to humans cannot be made with certainty. In response to 
these concerns, further cases were investigated to provide more information regarding the physiological 
effects of micropollutants on lower vertebrates and mammals: research conducted by Schultz et al. (2012) 
included the investigation of anatomical, physiological and behavioural responses of Fathead minnows 
(Pimephales promelas) to triclocarban (TCC) and triclosan (TCS), while the research conducted by 
Zenobio et al.  in 2014 tested the effects of TCC, as well as a combination of TCC and TCS with other 
micropollutants. This research presents a dataset that expands on a literature gap where effects of single 
micropollutants do not show the same response when those same micropollutants are mixed with others. 
This research also maintains environmental relevance, as the experiments are conducted using 
concentrations of micropollutants that are representative of those found in the environment.  
Micropollutants have been shown, through different studies, to have disruptive effects on vertebrate 
endocrine systems, and have therefore been attributed the collective term endocrine-disrupting chemicals 
(EDCs). Some micropollutants have been shown to have estrogenic effects within mammalian systems, 
and are aptly termed xenoestrogens, examples of which include substances like bisphenol A (BPA) 
(Spengler et al., 2001)  and the parabens, especially propylparaben.  
 
2.2.1) Parabens 
 
“Paraben” is the term used to describe the esters of ρ-hydroxybenzoic acid. The nature of the alkyl 
group attached to the carboxyl end of the acid determines the type of paraben (Jonkers et al., 2010), 
where a methyl, ethyl or propyl group indicates methylparaben, ethylparaben and propylparaben, 
respectively (Figure 2.1). Parabens are widely used as antimicrobial preservatives in cosmetics, PCPs 
and even food (Lemini et al., 2003). Propyl and/or methylparaben are present in at least 48% of PCPs 
and cosmetics (Núñez et al., 2008; Błędzka et al., 2014), and parabens are the second-most common 
ingredient found in cosmetics, second only to water (Cashman and Warshaw, 2005; Janjua et al., 
2007). The concentration of parabens in most PCPs is around 0.3% w/v (Soni et al., 2002) or 0.4% 
(SCCP, 2008) for individual parabens, or up to 0.8% for parabens included in combination (more 
than one paraben) (SCCP, 2008), which amounts to concentrations of about 3-4 g.L-1 and 8 g.L-1, 
respectively. Parabens are primarily included in PCPs because they show broad-spectrum 
antimicrobial activity against bacteria, yeasts and moulds (Błędzka et al., 2014) Their specific 
mechanism of action is not well understood, but research has shown that parabens could interfere 
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with mechano-sensitive channels in 
Escherichia coli, ultimately causing lethal 
changes in osmolarity due to disruption of 
osmoregulation (Nguyen et al., 2014). In 
addition to their antimicrobial properties, the 
use of parabens is popular because these 
compounds are inert, exhibit no noticeable 
colour or odour and possess low levels of 
systemic toxicity (Błędzka et al., 2014). The 
acceptable daily intake for methylparaben 
(over a decade ago) was 55 mg.kg-1.day-1 
(Soni et al., 2002). In 2004, the European 
Food Safety Authority then declared the 
acceptable daily intake was between 0 and 
10 mg/kg for methyl- and ethylparaben only 
(ESFA, 2004). Exposure occurs not only 
through ingestion (if in food) or through 
dermal absorption (in cosmetics and PCPs) 
but research shows that parabens can also be 
inhaled in households where paraben-containing products are used (Rudel et al., 2003, Canosa et al., 
2007). Methylparaben is estimated to be present in household indoor air at average concentrations of 
21 ng.m-3 (Błędzka et al., 2014) and the nebulised intake was determined to be around 13.8 ng.kg 
body weight-1.day-1 and 0.547 ng.kg body weight-1.day-1  inhaled by children and adults, respectively, 
based on average respiratory rates and respiratory volumes for these two groups (Błędzka et al., 
2014).  
 
Parabens were considered safe by the FDA over a decade ago (Soni et al., 2001). However, research 
has shown that parabens induce estrogenic effects similar to those induced by estradiol, (Routledge 
et al., 1998; Wróbel and Gregoraszczuk, 2014). In contrast, a study done by Aubert et al in 2012 
showed that parabens are converted to para-hydroxybenzoic acids (PHBAs) in blood plasma and 
they concluded that there appeared to be negligible effects in rats. They also commented on general 
levels of parabens in the human population and declared that parabens demonstrate a negligible effect 
on humans. This study, however, did not take into account long term effects of so-called “negligible” 
doses, nor did they consider investigating effects at the receptor level. Other research done on breast 
cancer cell lines MCF-7 and MCF-10A, showed that parabens (at 20nM test concentrations) 
stimulate estrogen receptor 1 gene expression (ESR1) in both cell lines (except for butylparaben, 
which did not affect ESR1 in the MCF-10A cell line) and ESR2 gene expression in MCF-7 cells 
(Wróbel and Gregoraszczuk, 2014). Since these cell lines are used to determine what compounds 
	  
Figure 2.1: Schematic showing a structural 
comparison of estradiol (E2) with the paraben 
group 
The structure shown is common to all parabens, with 
exception of the R group. The R group, indicative of 
the alkyl group, varies according to the different types 
of parabens. 
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contribute to the progression of breast cancer (in both males and females), it is very likely that long 
term exposure of parabens can contribute to estrogen-related cancers (Wróbel and Gregoraszczuk, 
2014).  
 
A more simplified approach to assess the direct effects of parabens on the human estrogen receptor 
in a transgenic yeast organism was described by Routledge and Sumpter in 1996. To supplement the 
contradicting information in the literature, this approach was utilised in this research to determine 
whether parabens are estrogenic, and therefore whether they can be considered potentially dangerous. 
The advantage of using the yeast assay is that it very elegantly shows the direct effects of estrogenic 
compounds at the receptor level in a simple, colorimetric assay. This recombinant yeast strain 
contains the human estrogen receptor (hER) gene within the genomic DNA in the nucleus, and an 
estrogen receptor element (ERE) on an exogenous expression vector within the cytoplasm 
(Routledge and Sumpter, 1996). A hybrid PGK promoter is inserted upstream of the ERE and a lacZ 
gene downstream of the ERE ((Routledge and Sumpter, 1996). Since the hER gene is located on the 
genome of the yeast, the receptor is always present in the yeast cell in proportion to the level of 
metabolism and expression of the genes on the chromosome. In the presence of estrogen, or an 
estrogenic compound, the estrogen ligand binds to the hER. Upon binding, the activated hER protein 
product acts as a DNA regulatory protein and binds to the ERE on the expression vector, which 
results in upregulating the expression of the lacZ gene downstream of the promoter. The lacZ gene 
encodes β-galactosidase, an enzyme that ordinarily would catabolise lactose and other disaccharides 
into monosaccharides, such as glucose and galactose, through cleavage of β-glycosidic linkages (Li 
et al., 2012). Chlorophenol red-β-D-galactopyranoside (CPRG), a structural analogue of β-galactose 
included in the assay medium, acts as a substrate for β-galactosidase (assembled by the yeast using 
the lacZ gene product). The product of the hydrolysis of CPRG is red/purple and quantitatively alters 
the medium colour. The degree of colour change can be measured spectrophotometrically and is 
indicative of the degree to which the test compound bound to the hER (degree of estrogenicity). This 
assay was conducted using methylparaben in the experimental design of this research project to 
demonstrate its effect on human estrogen receptors. A second yeast strain has also been developed, 
which contains the human androgen receptor (hAR) instead of the hER. The expressed hAR protein 
functions similarly to that of hER as they both are transcription factors that, upon activation by the 
binding of their native ligands, migrate to the nucleus to upregulate the genes to which they bind 
(Mooradian et al., 1987). Known native ligands that recognise, and bind to, the androgen receptor in 
vivo are testosterone and dihydrotestosterone (DHT) (Roy et al., 1999). The androgen receptor is 
closely related in structure to that of the progesterone receptor and therefore progestins or, indeed, 
progestin-mimics can bind competitively to the androgen receptor thereby blocking its function 
(Bardin et al., 1983, Raudrant and Rabe, 2003). 
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The apparent estrogenic activity exhibited by the parabens is not surprising, considering their 
structural similarity to estrogen at the site of the molecule where receptor-recognition occurs (see 
Figure 2.1). This structural similarity allows the paraben group of chemicals to act as estrogen 
receptor (ER) agonists, and indeed, parabens have been shown to induce estrogenic-like responses 
in yeast cells that exhibit this ER attached to downstream reporter genes. Estrogenic activity, through 
agonistic action of the ER, is noted in these transgenic yeasts through the upregulation of the reporter 
gene product in response to paraben exposure. Recent research by Wróbel and Gregoraszczuk in 
2014  showed estrogen receptor activity in MCF-7 breast cancer cells, with the upregulation of 
mRNA and protein products triggered by both ESR1 and ESR2 (Estrogen receptors 1 and 2) agonistic 
activity.  The evidence shows that the endocrine-disrupting activity of the parabens occurs and they 
are, consequently, not actually as benign as previously considered.  
 
2.2.2) Carbamazepine 
 
Carbamazepine is a pharmacological, anti-epileptic substance belonging to the benzodiazepine class 
of drugs (Katzung and Trevor, 2015). Carbamazepine is one of the many types of benzodiazepines 
available on the market. It is a scheduled medication sold under various proprietary names, such as 
Tegretol™ and Epitol™ (Drugs.com, 2015) prescribed for individuals with seizures (epilepsy). The 
drug is available in 100 -200 mg doses, taken at least once a day (DrugBank, 2005). Benzodiazepines 
function at the neuronal level by enhancing the activity of gamma-aminobutyric acid (GABA) and 
carbamazepine, specifically, works by inhibiting glutamate release at the glutamatergic synapse, 
stabilising the inactivated state of voltage-gated sodium receptor channels (Katzung and Trevor, 
2015). Benzodiazepines are surrounded by a relatively large degree of controversy, especially in 
chronic long-term usage. The reasons for this controversy are numerous, but the most clinically 
significant is likely the adverse effects that a patient will experience as a consequence of long term 
administration of benzodiazepines. Some of these long term adverse effects include iatrogenic 
(affliction resulting from clinical intervention) hypothyroidism due to the increased metabolism of 
triiodothyronine (T3) and tetraiodothyronine (thyroxine, or T4), and hypercholesterolæmia by 
increasing the levels of high density lipoproteins (HDLs) in the blood (Drugs.com, 2015). 
Carbamazepine also has a teratogenic effect, causing congenital malformation and birth defects 
(Novartis, 2015). Not only do benzodiazepines cause very undesirable long term effects, they also 
interact with a multitude of other chronic drugs. Carbamazepine interacts with Eltroxin™ (a synthetic 
medication for individuals suffering from hypothyroidism), oral contraceptives and hormone 
replacement therapy (HRT), antibiotics and antifungals and cardiac medication, among many others 
(Drugs.com, 2015). Unintended pregnancies through the interaction of carbamazepine with 
hormonal contraceptives has been reported (Novartis, 2015). The smallest known lethal dose in adult 
humans is 3.2 g, with the oral LD50 determined to be between 1100 and 3750 mg.kg-1 in rats 
(Novartis, 2015). The long list of contra-indications and side effects of carbamazepine becomes 
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significant when it is coupled to the fact that carbamazepine that enters the WWTP is removed with 
a very low efficiency (Zhang et al., 2008). In fact, it seems to actually accumulate in WWTPs in 
some cases, with effluent water containing more than the influent (Archer et al., 2017). This means 
these aforementioned interactive effects may be able to affect non-target individuals that merely 
consume water contaminated with carbamazepine, and other benzodiazepines.  
 
In addition, carbamazepine has been shown to 
have endocrine disrupting effects specifically 
affecting thyroid hormone function. In a study 
done by  Vainionpää et al. (2004), 
carbamazepine was shown to decrease the serum 
thyroid levels in young (prepubescent) girls. 
Carbamazepine induces degradation of 
tetraiodothyronine, or T4 (one of the hormones 
involved in thyroid function) and also may 
prevent the release of this hormone into the blood 
(ThyroidUK, 2015). In other words, it reduces 
plasma levels of T4. This is alarming, considering 
the thyroid is responsible for general growth and 
involuntary nerve functions, which will affect 
epileptic children who need to take this drug 
chronically. In the aforementioned study by Vainionpää et al., the effects on the serum thyroid levels 
was stated to appear reversible after withdrawal. While this may be the case, the long term effects of 
this pharmaceutical could not be assessed. Carbamazepine also appeared to cause lowered semen 
quality and decreased libido in men undergoing therapy (Reis et al., 2013), which suggests an 
endocrine disrupting effect on testosterone activity. The individuals who are undergoing chronic 
benzodiazepine therapy contribute to the levels of this class of drugs in the water system, due to the 
fact that 28% is excreted unchanged (RxList, 2015). Therefore, this 28% has the potential to 
indirectly affect other organisms coming into contact with the water in which the drug is present. 
 
Carbamazepine is found to be present in wastewater all over South Africa ranging in concentration 
from less than 100 ng.L-1 in some regions (Odendaal et al., 2015) to over 800 ng.L-1 in others 
(Archer et al., 2017), and is considered one of the three major contaminants of emerging concern in 
South Africa (Odendaal et al., 2015). Concentrations of carbamazepine in South African WWTPs 
have been described in Table 2.1 above.  
 
 
 
	  
Figure 2.3: The structure of carbamazepine  
A psychoactive anticonvulsant compound used 
in the treatment of epilepsy, that have shown 
thyrotropic effects in humans (Vainionpää et 
al., 2004). 
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2.3)  Biofilms 
 
Microbial aggregations, such as biofilms, represent a major component of pollutant removal in the 
secondary stage of WWTPs (Pescod, 1992). Biofilms are a stationary amalgamation of living microbial 
cells surrounded by a matrix of extracellular polymeric substances (EPS) (Figure 2.3, in section 2.3.1). 
This is the growth form of bacteria that predominates in the environment (Henrici, 1933; Costerton et 
al., 1999; Hall-Stoodley et al., 2004; Romeo, 2008), and serves as a protective barrier against detrimental 
environmental conditions while also providing a mutualistic environment whereby many species 
undergo modular processes that fit together in one nested biofilm. Biofilm systems are extremely 
complex in their structure and function. The biofilm may also provide different pockets, or micro-
environments, of anaerobic zones interspersed with aerobic zones. The different modular parts provide 
different degrees of stress which, in turn, provides an environment conducive to genetic mutation and 
reshuffling (Boles and Singh, 2008).  
 
2.3.1) Structure 
Biofilms consist of a complex, intricate combination of the resident microbial cells and a gelatinous, 
protective matrix in which the former are enveloped (Lasa, 2006; Romeo, 2008). Together, the two 
form the living and non-living components of the biofilm, respectively, and the two components 
function together to create an extremely adaptable and optimally functional miniature ecosystem. 
Biofilms provide an alternative living state for microbial organisms, enabling many metabolic and 
Figure 2.3 Basal layer of a biofilm viewed via light microscopy (1000X) 
The image was obtained from real-time biofilms grown in flow cells using the reactor for the experimental design 
of this research. The image was taken with 100X oil immersion objective using  a 2MP CMOS chip microscope 
camera. 
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physiological abilities of which the individual, planktonic cells may not be capable of executing 
(Allison, 2003; Gilbert et al., 1997).  
 
The defining characteristic of the biofilm is widely considered to be the extracellular polymeric 
substances, or EPS. It is often used interchangeably with the term “matrix”, or “extracellular matrix” 
(ECM), to describe the entire non-cellular portion of the biofilm. A combination of polysaccharides, 
proteins and lipids form the matrix, of which there are two types: the capsular and slime types 
(Allison, 2003). The former refers to the part of the matrix that is intimately associated with 
individual cells, while the latter refers to that which connects the capsular parts of the matrix together. 
This part of the matrix is what is ultimately responsible for the formation of the multiple 
microenvironments within the biofilm which, in turn, is an important factor that allows for microbial 
members of varying environmental requirements to function together as a community. Each biofilm 
is unique in the microbial species present, the relative abundance of these species, as well as the 
types of microenvironments created within the biofilm. 
 
2.3.2) Formation 
 
The formation of the biofilm is a complex, multifaceted process involving many physiological 
cascades and communicative interactions between the organisms making up the biofilm. The 
currently accepted school of thought is that biofilm formation follows five concurrent and 
genetically-distinct phases (Donlan, 2002; Dunne, 2002; Davey and O'toole, 2000; P. Stoodley et al., 
2002). Understanding the fundamental molecular mechanisms of biofilm formation was determined 
through a series of studies done based on biofilm assays conducted using mutant phenotypes of gram-
negative Proteobacteria (O'Toole and Kolter, 1998a; O'Toole and Kolter, 1998b; Pratt and Kolter, 
1998; Watnick et al., 2001; Watnick and Kolter, 1998). The five phases are (as summarised by 
Romeo (2008)): surface attachment, monolayer formation, migration (formation of multiple layers), 
EPS production and maturation. The stages of major significance that will be discussed are surface 
attachment and ECM production. 
 
Surface Attachment 
Surface attachment differs in motile and non-motile bacteria, largely because the surface 
components and appendages they exhibit are different. It is in these components/appendages 
that the mechanism of attachment to surfaces is determined.  
 
Non-motile species express surface adhesins, and the expression of these adhesins is 
upregulated in the presence of a suitable attachment surface (Gotz, 2002). These adhesins 
essentially allow the individual bacterial cell to attach more readily to other neighbouring 
bacterial cells and to the nearby surface, by increasing their overall “stickiness” (Romeo, 2008; 
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Gotz, 2002). The molecular mechanism seems to involve the Biofilm-associated proteins (Bap), 
or their related homologs, in multiple bacterial species. The Bap related surface proteins were 
found in Staphylococcus aureus (Lasa and Penadés, 2006), while other, genetically-related 
proteins have been characterised in other bacterial species (Latasa et al., 2006). These 
homologous proteins serve the same function: attachment, and ultimately, are responsible for 
biofilm formation. The mechanism through which these Bap-related proteins mediate biofilm 
formation is largely unknown, but due to their large amino-acid repeat domains, it is likely the 
mediation of adherence is due to homophilic interactions between the Bap proteins themselves 
(Latasa et al., 2006), where the association of Bap proteins may serve to bind bacterial clusters 
(Latasa et al., 2005). 
 
Motile species use a markedly different mechanism for surface attachment, by actively 
swimming and aggregating to the surface onto which adherence is desirable (Romeo, 2008). 
They use their motility organelles (pili, curli or flagella) to migrate to the surface after which a 
physiological cascade ensues, causing a drastic structural change resulting in attachment and 
entrance into a lifestyle switch (Romeo, 2008). This lifestyle switch is characterised by a change 
from motility into sessility, with the downregulation and ultimate cessation of the expression of 
the genes that code for motility organelles. Studies conducted by Pratt and Kolter (1998) showed 
that mutants deficient in flagella production were markedly defective in the formation of 
biofilms. Before permanent adherence occurs, the bacteria first adhere transiently. The transient 
period of adherence results in either stable association with the surface, entering into permanent 
sessility, or in a return to the planktonic state. Once the bacterial cells enter into a sessile state, 
they begin to produce the extracellular matrix that ultimately forms the structural backbone of 
the biofilm.  
 
The switch from motility to a sessile, biofilm state involves complex molecular interactions. 
These interactions have been extensively studied in the model bacteria, Bacillus subtilis. It 
essentially involves the activity of a regulator repressor protein which, during times favouring 
biofilm formation, will cease active repression of the genes involved in matrix formation 
through an antagonistic process that inhibits the repressor protein (Branda et al., 2006). In 
Bacillus subtilis, this repressor protein is called SinR. It is constitutively produced and therefore 
ensures the bacteria remain in a motile phase. The SinI and YlbF/YmcA proteins serve to 
antagonise SinR activity in the case where biofilm formation becomes favourable. SinI activity 
is closely linked to Spo0A concentration (Romeo, 2008), a protein also associated with 
sporulation in periods of extreme stress such as nutrient depletion (Snyder and Champness, 
2007).  
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Extracellular Matrix (ECM) Production 
The production of the extracellular matrix (ECM), or the EPS, by the biofilm occurs through 
the transcription of genes encoding EPS components, called the eps operon (Kearns et al., 2005), 
along with other protein components, that are assembled together. Different species of bacteria 
produce different types of protein components. These EPS components are produced with 
varying levels of efficacy, but it is assumed that bacteria producing more EPS components still 
serve to aid other species in adhering to this matrix, regardless of the amounts of EPS 
components that they produce. In other words, mixed microbial biofilms may be more effective 
at forming biofilms than pure species due to the synergistic effects of the different types of EPS 
components on matrix formation. The EPS is involved with how the different species arrange 
within the biofilm, resulting in the formation of different microenvironments (Costerton et al., 
1999). It must be noted that EPS, and subsequent microenvironment formation is unique to each 
biofilm that forms: not one biofilm will have the same abundance and arrangement of 
microenvironments as another. 
 
Critical Evaluation of this Model 
The five stages of biofilm development as described above is extremely oversimplified and 
arguably, temporally inaccurate, because the above five steps do not occur sequentially but 
instead overlap. Bester et al. (2009) showed that biofilms continually and consistently release 
planktonic cells during the entire developmental process, from as early as 6 hours after initial 
introduction of inoculum and attachment (Bester et al., 2009). Prior to this, Tolker-Nielsen et 
al. (2000) concluded that planktonic cells are released in multiple stages of the Pseudomonas 
biofilm formation, not just in the final one. In addition, the number of planktonic cells released 
is also indicative of the level of development of the biofilm. Biofilms release increasing amounts 
of planktonic cells into the bulk flow over time, eventually reaching a steady-state where the 
maximum amount of cells is released continuously.  
 
2.3.3) Genetics 
 
Sessile (biofilm) cells differ markedly from free-living planktonic cells at the molecular level, for 
instance in terms of the diversity of mutants generated in the respective growth mechanisms (Boles 
et al., 2004). This is because biofilms show an increased capacity for generating mutants in the 
absence of external mutagens or stress (Boles and Singh, 2008). Endogenous oxidative stress has 
been postulated as the reason behind the increased mutation rate in biofilms. Studies conducted by 
Boles and Singh in 2008 determined, through gene knockouts of recA and katA (encode for double-
stranded DNA repair enzymes and catalase, respectively), that a combination of oxidative stress, lack 
of antioxidant processes, and functional double-stranded DNA break repair are required to produce 
phenotypic diversity in a pure culture biofilm (Boles and Singh, 2008). The presence of 
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microenvironments in the biofilm expose the microbes to different degrees of environmental 
conditions which, in turn, selects for certain advantageous mutants over time. It is postulated that the 
higher diversity of mutants generated in a biofilm serves as “insurance”, ensuring that at least some 
of the population survives in adverse environmental changes due to the presence of many mutant 
phenotypes.  
 
2.3.4) Function 
 
The true function of a biofilm is under contention, where some research tends towards biofilms as 
purely a survival mechanism, some towards biofilms as a mechanism for proliferation, and some 
concluding that it is both. Biofilms do seem to function as a survival mechanism. In the medical field, 
biofilms are seen as a mechanism through which bacteria evade removal from catheters, acetabulum 
(hip) replacements and even heart valves. In clinical treatment, bacterial biofilms protect cells deep 
in the biofilm from therapeutic levels of antibiotics (Suci et al., 1994; Lewis, 2001). The biofilm also 
creates a physical barrier that enables evasion of contained cells from the host immune responses, 
both innate (complement-mediated lysis and general phagocytosis (Kindt et al., 2007)) and adaptive 
(opsonisation) (Janeway et al., 2001; Kindt et al., 2007; Aslam, 2008)). The presence of the EPS in 
the biofilm protects the bacterial cells deeply enveloped within, and therefore an immune response, 
innate or adaptive, can be hindered from removing the cells since these mechanisms rely on the 
recognition of certain extracellular ligands (Major Histocompatibility Complexes in the case of 
innate immunity, and antigens in the case of adaptive immunity (Kindt et al., 2007)) which are 
inaccessible when covered by EPS. A similar effect occurs with antibiotics, which require direct 
access to the target bacterial cell. The EPS serves as a defensive barrier, and the antibiotic has to 
diffuse through the EPS matrix to reach the target cells. In this way the EPS matrix and the biofilm 
serve as a dilution system: the antibiotics diffuse into the biofilm matrix, each antibiotic at different 
degrees (Aslam, 2008), but not all the molecules reach a target, essentially “diluting” the antibiotic 
below its’ therapeutic dose in the biofilm (Stewart, 2003). Not only does the biofilm hinder antibiotic 
access to the cells, but some cells within the biofilms undergo metabolic changes, resulting in either 
dormancy or persister cell status, which also reduces the efficacy of antibiotics (Lewis, 2005). This 
is because cells that have entered dormant or persister cell status reduce, or altogether switch off, 
some metabolic processes such as protein synthesis or DNA replication, the enzymes of which are 
targets of the antibiotics. This essentially renders the antibiotic ineffective, since the target is not 
available for attack. Biofilms may also release large numbers of planktonic cells in response to 
severely detrimental environmental changes (nutrient depletion etc.) (Aslam, 2008), which also 
appears to be a survival mechanism, ensuring the progeny cells are able to establish a new biofilm 
elsewhere should the existing one not survive. In these ways, biofilms are intended as a survival 
mechanism.  
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There is also evidence in the literature of biofilms as a proliferative mechanism, although these are 
not as numerous as the evidence for biofilms as a survival mechanism. This may be purely because 
the biofilm as a proliferative mechanism is not clinically relevant, while the recalcitrance (through 
survival mechanisms) is of great clinical relevance and is therefore researched and reported upon 
more often. Evidence of biofilms as a means of proliferation and growth is remarked upon more 
often in mixed microbial biofilms. It appears that a biofilm consisting of multiple species functions 
almost as a higher organism, with mutualistic and synergistic activities between the different 
microbial species. It was found that the formation of Escherichia coli PHL565 biofilms was 
improved and enhanced by the presence of Pseudomonas putida (Castonguay et al., 2006), since the 
former showed very poor biofilm-forming ability in a pure culture (Castonguay et al., 2006). 
Research by Hassan et al. (2004) showed that the establishment of Listeria monocytogenes (a 
pathogenic microbe) is enhanced when in the presence of mixed Pseudomonas putida biofilms. 
Biofilms also serve as a site for horizontal gene transfer between organisms, both via intraspecies 
and interspecies interactions, and therefore allows microbes to acquire genes that are advantageous. 
Research conducted by Weigel et al. (2007) on a patient with a nephrostomy tube showed that there 
is potential for antibiotic resistance genes to be transferred between bacteria in the 
microenvironments created by the formation of biofilms. Metabolic interactions also occur in 
biofilms, whereby a compound is degraded by more than one species. This phenomenon, called co-
metabolism, allows microbes to degrade a substrate that would otherwise be non-degradable in pure 
cultures. The process involves sequential degradation of a compound, whereby the product of the 
first step of degradation (conducted by one microbial species) becomes the substrate for degradation 
by another species of microbe (Biology-Online, 2005). It was shown that a mixed culture of multiple 
bacterial strains was able to mineralise significantly more of the pharmaceutical compound 
paracetamol, than pure cultures of the separate microbial strains (Zhang et al., 2013). This same 
research group also showed that the three microbial strains were all required in order for paracetamol 
to be completely degraded (Zhang et al., 2013). This interaction shows the potential of co-
metabolism between bacterial strains in batch culture, and therefore shows that mutualistic 
interactions between bacteria do exist.  The existence of mutualistic activity between microbes in 
batch culture shows that biofilms, by extension, may also serve to provide the environment to allow 
different species to interact, and cometabolise substrates, with each other.  
 
The arguments can be put to rest, however, by assuming that biofilms are not only for survival or for 
proliferation, but rather that they are meant for both functions, and that the function they perform 
depends on what is necessary at the time. This shows the true degree of functional plasticity that a 
biofilm possesses. The biofilm appears to function as a very flexible system made up of different 
microcolonies of interacting microbes. The way that microbes function in a mixed microbial biofilm 
may be akin to multiple tissue and organ systems that work together to make up a fully-functional 
organism, capable of adapting to changes in the environment. It must be appreciated that biofilms 
Stellenbosch University  https://scholar.sun.ac.za
21	  
	  
are more than just a way for microbes to survive or produce progeny: it is a system of interacting 
microbes, like a city of people, that function in an intricate way to achieve superior purposes that 
would be impossible were they to act individually. 
 
Bacteria, not necessarily only when confined to the biofilm state of growth, possess a system known 
as catabolite repression. This is a molecular-based process that involves the inhibition of certain gene 
products for the metabolism of other carbon sources, such as lactose and arabinose, in the presence 
of glucose (Snyder and Champness, 2007). Microbes are therefore able to switch off energy and 
resource-expensive pathways in the presence of a carbon source that is more energy efficient. In the 
presence of glucose, and its metabolites, the cell produces repressors that bind to the operons of genes 
for metabolism of other carbon sources (Snyder and Champness, 2007). In the absence of glucose, 
or if glucose is depleted, the cell will then change the state of the repressor proteins. The type of 
carbon source present in the immediate environment of the cell determines which operon is activated. 
For example, if lactose is present then the lac operon is transcribed. The molecular processes are 
quite intricate and there is more than one type of catabolite repression, therefore the specifics will 
not be discussed here. The presence of a mechanism like catabolite repression in the bacterial genome 
shows the energy-efficiency with which bacteria function, further emphasising their plasticity 
(Snyder and Champness, 2007). 
	  
2.3.5) Effects of Micropollutants on Biofilms 
 
There is a fair amount of literature on effects of biofilms on micropollutants, while the amount of 
data and research available on the effects of micropollutants on biofilms is very limited. This is 
partially because the effect microbes have on the pollutants (the removal thereof) is understandably 
of more significance than the effect the compounds may have on the biofilms. Knowledge of how 
micropollutants affect biofilms may provide insight into how it interacts with the cells or the EPS. 
This knowledge can then be used to manipulate and increase the removal of the compound by 
modifying the biofilm via the alteration of its’ physiochemical environment, by changing the existing 
WWTP to include a stage that is designed to enhance micropollutant removal via changing the 
physiochemical environment of the biofilms. The gap in knowledge on how the pollutants physically 
and biochemically affect biofilms is large. Therefore, the effects of some micropollutants on biofilms 
will be investigated within the experimental design of this thesis, in order to determine the extent of 
effects, if any, these compounds have on biofilms. The greater the degree of effects on biofilms will 
result in more significance being placed on investigating these effects. 
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2.4) Biomimicry as a Conceptual Framework for the Study of Biofilms in the Context of 
Bioremediation and Micropollutant Removal 
 
Bioremediation has received increased recognition, with the general change in mindset towards more 
ecologically-orientated and sustainable solutions, especially when it comes to the removal of pollutants 
from the environment. Bioremediation is essentially the introduction of microbes to a site with the 
specific intention of exploiting their metabolic processes in order to remove pollutants in that area, or 
to harness the metabolic potential of the resident microbial communities for this purpose (Anderson, 
1995). Bioremediation has been used in the environment in some instances with great success, such as 
the use of dispersal to facilitate the cleanup of the Deepwater Horizon oil spill that occurred in the Gulf 
of Mexico in April of 2010. The remediation involved the use of dispersing agents, which served to 
emulsify the oils into smaller droplets, which facilitated faster microbial degradation through increased 
surface area exposure (Biello, 2010). The dispersal agent also served as a food source for the microbes 
(natural microbes living in the ocean), thereby increasing their numbers and further accelerating the 
bioremediative process (Biello, 2010).  
	  
In the laboratory environment, it was shown that biofilms of Pseudomonas aeruginosa N6P6 were 
capable of degrading polycyclic aromatic hydrocarbons (PAHs), with an increase in the degradation 
occurring in proportion to the increased expression of the lasI gene (Passador et al., 1993, Mangwani et 
al., 2015). The product of the lasI gene is involved in the synthesis of the N-acyl-homoserine lactone 
(AHL) auto-inducer which is involved in quorum sensing (Mangwani et al., 2015). Quorum sensing is 
a mechanism of regulating expression of certain genes in response to changes in the size of a cell 
population (Miller and Bassler, 2001). The implication of this finding is that biofilms are capable of 
degrading certain compounds, like PAHs, when cells that recognise and produce auto-inducers are 
present. Benzene, a carcinogenic environmental pollutant (Dean, 1985), has been shown to be degraded 
by microbial consortia in both aerobic (Gibson and Subramanian, 1984, Smith, 1990) and anaerobic 
conditions (Edwards and Grbić-Galić, 1992). The range of the given examples shows at least 30 years’ 
worth of research on the biodegradative abilities of microbes. Therefore, it would seem an obvious 
solution to look to microbes for the degradation of the micropollutants that are becoming a problem in 
water sources, especially those that appear to be recalcitrant. The extreme plasticity and adaptability of 
microbial biofilms provide the best opportunity for selecting for consortia that are adapted to degrade 
one or more of these micropollutants. Since mixed microbial biofilms appear to have the greater 
potential for flexibility, due to the large variety of microbes and associated genetic and metabolic 
functions, the focus should arguably be on these mixed consortia for remediation of water containing 
low concentrations of micropollutants. These biofilm consortia may be found in natural water sources 
(rivers, lakes and dams), which is often an added advantage, since these microbes have already been 
exposed to the micropollutants in the water systems in which they reside. The key is to find a natural 
system that enables maximising the exposure of a microbial consortium to the polluted water source. 
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Despite the demonstrated micropollutant removal potential of microbes, the use of these mechanisms to 
remediate contaminated environments often fail. This is because the remediative processes, that work 
in a pilot or laboratory-scale study, are difficult to apply to the scale of the larger, real environment due 
to the presence of variables that did not exist in the closed laboratory (or pilot) environment. To solve 
that problem, natural systems may be used as inspiration, in order to create a system that would allow 
for these optimal exposure conditions, mimicking a natural system that already conforms to these 
criteria. Biomimicry offers a potentially powerful approach in the search for solutions to the removal of 
recalcitrant micropollutants and other compounds of concern (Lurie-Luke., 2014). 
 
Biomimicry has become somewhat of a catchphrase since the term was introduced by Benyus in 1997, 
leading many to think it is a relatively new concept. However, this is not the case. Biomimicry has been 
around since, at least, the time of the Ancient Greeks. Biomimicry has multiple, arbitrary, definitions 
but in essence it is the use of a structure, process or design that already exists in the natural environment, 
and adapting it to perform in an industrial setting in an innovative way, in order to solve the challenges 
of humans (TheBiomimicryInstitute, 2015). 
	  
It must be noted that there are also many other biological terms that appear to be related to biomimicry, 
but are not. Examples are the terms bio-utilisation and bio-assistance, which refer to the harvesting of 
an organism or product and the domestication or modification of an existing organism, respectively 
(Benyus, 2009). Biomimicry is different in that it involves the creation of an apparatus that emulates 
what its muse does, without the presence of said muse.  
 
One of the earliest recorded examples of biomimicry is that of Icarus and Daedalus and, although it is 
part of Greek Mythology, it still serves as an elegant example of humans employing biomimetic 
principles. The mythological tale follows Daedalus and his son, Icarus who were imprisoned in the 
Labyrinth by Minos (Kindberg and Turner, 2010; GreekMyths, 2016). Daedalus, having built the 
Labyrinth for Minos, knew how intricate it was and he knew the coast of Crete was littered with guards 
(GreekMyths, 2016). Therefore, they could escape by neither land nor sea. Daedalus realised that they 
would need another way out and saw the flight of birds that came and went as they pleased. He then 
fashioned working wings out of branches and wax, and he and his son Icarus managed to escape the 
Labyrinth through flight. The rest of the story is very well known among popular culture: Icarus, in his 
excitement, flew too close to the sun despite his fathers’ warnings. He then drowned in the sea (later 
called the Icarian Sea (GreekMyths, 2016)). The point of the story, in the context of biomimicry, is that 
Icarus and Daedalus observed the flight of birds and were able to copy the structure and function that 
the wings served the birds. Through innovation (using limited resources), the two men were able to 
mimic the wings and leave the Labyrinth. This may be just a myth, but the story serves as a very elegant 
example of what biomimicry is, and illustrates just how long the concept has been around.   
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Other, more recent, biomimetic processes have since been created. One of the most overlooked examples 
is that of Velcro, the material that comes in two complementary strips that serve to attach two parts or 
surfaces together upon application of pressure. The concept was inspired by burrs, which have tiny 
hook-like protrusions extending from the seed capsule, that attached themselves to clothing and animal 
fur. One side of the Velcro strip has the same hook-like protrusions and the complementary side of the 
Velcro is a soft, brushed textile to which the hooks attach (shown in Figure 2.4). This example shows 
how biomimicry can be applied in a very simplistic, elegant way. The mimicry of the attachment of 
burrs to animal fur is simply structural biomimicry, but there are other facets of biomimicry, making it 
a concept that is much more complex than its definition belies. Another example of biomimicry is that 
of the ‘gecko pad’, a handheld pad that was designed based on the pad of a geckos’ foot, by Biomimetics 
and Dextrous Manipulation Lab. The apparatus is designed such that it can support large weights upon 
application of the pressure to the pads held against a surface (Cutkosky, 2016). It also has the added 
feature that it can exhibit the same adhesive force regardless of its size (Cutkosky, 2016). These two 
examples serve as a very elegant and remarkable application of biomimicry in technology, although 
there are many other examples of biomimetic constructs.   
 
The diagram in Figure 2.5 shows the principles of biomimetic designs, or “lessons to be learned from 
nature” (Biomimicry3.8, 2013) colloquially called “life’s principles” by the Biomimicry Group. The 
“Life’s Principles” pie-chart shows the main principles a design should incorporate in order to mimic 
nature as closely as possible. For example, the story of Icarus and Daedalus mimicking the wings of 
birds to escape the Labyrinth is an example of the application of the “resource efficient”, “locally-
Figure 2.4: The biomimetic design of Velcro and its’ inspiration (a burr attached to animal fur) 
Image drawn by the author 
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attuned and responsive” and the “evolve to survive” principles. Daedalus “fit form to function” by 
designing the wings in order to facilitate flight for him and his son. They used resources that were readily 
available to them within the Labyrinth, and therefore had to be inventive in order to achieve their goal. 
The “evolve to survive” was applied quite literally by replicating the birds’ wings (“strategies that 
work”) to a form that they could use to fly. These principles may be applied to other biomimetic ideas 
to ensure they remain as nature-inspired as possible.  
	  
	  
The Eco-Machine™, created and developed by John Todd Ecological Design, is another example of a 
nature-inspired (biomimetic) process. It was one of the initial aims of this thesis to evaluate an Eco-
Machine™ to be built in a township called Langrug, in Franschoek in the Western Cape, for its water 
treatment efficiency. Although this aim was not included in this thesis due to extended delays in its 
Figure 2.5: “Life’s Principles”.  
These are the conditions under which nature operates, and which should be applicable to biomimetic 
constructs. Image reproduced from Biomimicry3.8© 2013 Biomimicry3.8, The Biomimicry Group (image is 
licensed under creative commons) 
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construction, the investigation of the removal efficiency of these constructs in the paradigm of 
biomimicry still applied to this research.  The Eco-Machine™, also referred to as a Living Machine, is 
essentially a man-made, or mimicked, assembled wetland ecosystem (Woolley-Barker, 2013). The 
construct consists of a network of interconnected, consecutive tanks through which the wastewater 
moves during treatment. The components of these Living Machines include primary and equalisation 
tanks, where solids settle and water levels are buffered, respectively (LivingMachine, 2012), followed 
by the wetland cells. These wetland cells are numerous and each contain a selection of organisms from 
various kingdoms: Plantae, Animalia, Fungi, Protists, etc. The cells each contain a combination of 
plants, with associated root and sediment biofilms, algae, fungi and other detritivores, as well as fish 
and other animals. The components all function together as a closed ecosystem, through which the 
wastewater is treated. The members of each cell of the ecosystem remove the organic contaminants from 
the water by either incorporating these contaminants into their own biomass or catabolism of the larger 
organic contaminants,  gaining energy as a result, into building blocks and simple compounds (nitrates, 
carbon dioxide and water, etc.) that are used as final electron acceptors, thereby removing them from 
the water. In return for breaking down the contaminants from the water, the plants and associated 
organisms grow in order to produce an aesthetically-pleasing , yet functional, “garden” effect.  
	  
The Living Machine, as described above, as well as the Eco-Machine™, like the one that is still to be 
built at Langrug, is not purely biomimetic but rather a combination of bio-assistance, bio-utilisation and 
biomimicry (Woolley-Barker, 2013). The biomimetic aspect involves the mimicry of a wetland 
ecosystem in nature. The components of the system, however, are obtained from nature as is and are 
incorporated into the construct, which is bio-utilisation. The combination of different organisms as 
separate components into each cell is bio-assistance, where the combination of the organisms allows 
humans to achieve a specific goal (water treatment, in this case). The efficacy of constructed wetlands 
in the removal of pollutants from wastewater has been well researched. A study conducted by Hijosa-
Valsero (Hijosa-Valsero et al., 2010a) showed that a constructed wetland/pond hybrid shows 
comparable removal efficiencies of micropollutants such as naproxen, ibuprofen and caffeine to that of 
conventional WWTPs. They also postulated that the presence of plants improves the removal 
efficiencies of some micropollutants (Hijosa-Valsero et al., 2010a). Constructed wetlands also showed 
more promise in the removal of micropollutants than did a conventional WWTP receiving the same 
influent wastewater (Hijosa-Valsero et al., 2010b). This is especially true for the more recalcitrant 
compounds, such as carbamazepine, which  was better removed by the constructed wetlands than by 
conventional WWTP (Hijosa-Valsero et al., 2010a; 2010b). 
	  
While biomimicry is advantageous in inspiring humans to design eco-friendly, sustainable and nature-
inspired systems that do not contribute to pollution and environmental damage, there are certainly 
limitations. Firstly, humans are limited to what they can build with synthetic materials. In other words, 
in order for something to be biomimetic, it must be a synthetic construct that is bio-inspired but does 
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not actually use the inspired organism (Benyus, 2009). This limits biomimicry to the applications that 
can be mimicked. There are limits to what humans can build, but nature has made some uniquely-
functioning systems which humans can manipulate, but not emulate. Bacteria are an example: single-
celled organisms that respond with plasticity to their environment through cues. They contain genetic 
material that encode millions of different functions. They are capable of expressing these genes in an 
energy-efficient manner, expressing only those they require, while managing to adapt to environmental 
changes. All of this is controlled by nothing more than their chromosomal (and extrachromosomal) 
material. Humans, while currently unable to emulate such a prototype, can manipulate and alter these 
functions to harness and commandeer this efficient bacterial machinery for solving wastewater treatment 
problems (through bio-utilisation and bio-assistance). Biomimicry (as well as bio-assistance and bio-
utilisation) can provide inspiration as means to achieve this. 
 
Another consideration, which pertains specifically to the wetland-mimicking constructs, is that because 
it is a natural system, it is limited by the systems' carrying capacities. The system uses living organisms 
that work together, but these organisms are limited with regard to the volumes of water that they can 
process. In other words, the amount of water that can be processed adequately in a specific time frame 
may be limited within these constructed wetlands. If the treatment of larger volumes of water is required, 
the wetland-mimic must be increased in physical size, in order to handle larger volumes without a 
reduction in efficacy. This was also reported in the literature, where it was stated that constructed 
wetlands work best for small populations, due to the large surface area required per individual, or rather, 
the smaller volumes that can be handled by these systems (Kadlec and Wallace, 2008, Hijosa-Valsero 
et al., 2010a). Therefore, it is essential to thoroughly assess the abiotic and biotic thresholds of these 
systems in order to optimally incorporate them into the environment and ensure no further contamination 
of surface waters occurs as a result of exceeding these maximum capacities. 
 
Biomimicry is an excellent concept that challenges companies, as well as the innovative individual, to 
create solutions to man-made problems by adhering to the rules (“life’s principles”) that are found in 
nature. The purpose of biomimicry is to create sustainable solutions that are eco-friendly, and therefore 
do not further contribute to the problems that need solving, while sourcing the answers from natural 
systems (Benyus, 2009). While the concept does have its advantages, its limitations cannot be ignored. 
Humans are still reliant on the activities of microorganisms, the genius of which cannot yet be 
synthetically reproduced.  So, while the concept of biomimicry is a great way to invent new bio-inspired 
constructs and products, the merit of using bio-assistive and bio-utilisation processes and ideas should 
not be overlooked, but rather included in biomimetic designs. 
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Chapter 3: Materials and Methodology 
 
3.1) Preparation of the Inocula for Experimentation 
 
3.1.1) Pure Culture Inoculum 
 
Pseudomonas sp. strain CT07 (GenBank Accession number DQ 777633; (Bester et al., 2005)), isolated 
from a cooling tower, was used for pure culture studies. Strain CT07 was cultured in 3 g.L-1 tryptone soy 
broth (TSB) overnight at 26oC. It was then streaked out onto tryptone soy agar (TSA: 3 g.L-1 TSB (Biolab, 
Merck); 12 g.L-1 bacteriological agar (Biolab, Merck)) to make a working stock from which overnight 
cultures were inoculated. The remainder of this culture was then aliquotted into sterile cryogenic tubes 
with 80% glycerol (uniLAB®, Merck) to a final concentration of 40% glycerol. These cultures were 
stored at -80oC and used as inoculum in all subsequent experimentation.  
 
A calibration curve to establish the relationship between optical density at 600nm and cell concentration 
was obtained in order to standardize inoculum size for minimum inhibitory concentration (MIC) and 
minimum biofilm inhibitory concentration (MBIC) determinations. In essence this was achieved by 
preparing an overnight culture of CT07 in 3 g.L-1 TSB supplemented with 1% glucose, and then making 
2mL volume dilutions (using 0.9 % saline as the diluent) of this overnight culture in ratios of saline to 
overnight culture ranging from 1:1 to 79:1. 
 
Each dilution was measured with a spectrophotometer (Spectroquant® Pharo 300, Merck™) at a 
wavelength of 600 nm, after a blank calibration with 0.9% saline, using 1 mL of sample in 10 mm 
cuvettes. Each of the different dilutions were subjected to a separate 10-fold dilution series in sterile 0.9 
% saline and plated out onto TSA agar plates, supplemented with 0.06% glucose. The plates were 
incubated for 48 hours at 26oC and the respective colony forming units were counted. The data obtained 
was used to construct a curve displaying optical density against the logarithm of cell concentration. 
	  
3.1.2) Mixed Culture Inoculum 
 
3.1.2.1) Cultivation of Mixed Culture 
 
Since mixed cultures are inconsistent with respect to species composition and relative abundances, a 
single sample was used to generate all inocula to be used for subsequent experimentation. To achieve 
this, a simple perfusion column was constructed to allow for the biofilm-forming organisms to colonize 
the surface of 25 mL 3mm glass beads packed in a 60 mL syringe, for subsequent use as the source of 
inoculum (Figure 3.1). 
The perfusion column was positioned in the opening of an Erlenmeyer flask (see Figure 3.1), and 
attached to a peristaltic pump (Watson-Marlow® 205S, Watson-Marlow Limited) via silicone tubing 
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(2 mm inner and 3 mm outer diameter). The apparatus was then sterilised with 20% NaOCl 
(ChlorGuard®, Prime Cleaning Supplies) for an  hour. Sterile reverse osmosis (RO) water was allowed 
to drip through for 24 hours to dilute the spent NaOCl out of the apparatus. Sterile TSB (3 g.L-1) was 
flushed into the system to displace the water. Subsequently, a sample of activated sludge from the 
Stellenbosch Municipality WWTP (previously collected in a 1.5mL Eppendorf® tube), of 
approximately 10 µL was added to the column. The flow rate of growth medium supplied by the 
peristaltic pump was adjusted to 15 mL.h-1 and left to continually perfuse over the beads for 7 days.  
The column was gently agitated daily to allow the culture to distribute evenly between the beads. The 
beads were then aseptically poured into a sterile petri dish and distributed into 1.5 mL Eppendorf® 
tubes containing 500 µL of 40% glycerol. Some samples were frozen at -80oC for long term storage 
and the remainder, used for working stocks, were stored at -20oC.  
	  
 
3.1.2.2) Reproducibility of Growth Patterns 
 
A calibration curve for optical density vs. cell concentration was performed for the mixed microbial 
inoculum to ensure consistent cell concentrations for MIC determinations. This was accomplished by 
aseptically dropping 3 biofilm-covered glass beads (created according to the protocol in 3.1.2.1) into 
Figure 3.1: Bead inoculum perfusion column 
Design of the perfusion column (left) and the apparatus as constructed in the laboratory (before 
addition of any medium or inoculum) on the right. 
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triplicate sterile test tube containing 10 mL TSB (3 g.L-1) supplemented with 1% D-glucose and 
incubating overnight at 26oC. This overnight cultures were then used to create a range of dilutions. 
	  
The optical density of each dilution was measured at 600 nm and simultaneously plated out on TSA 
after performing a 10-fold dilution series, as was conducted for the CT07 pure culture in section 3.1.1. 
The data was recorded in a table and a linear curve obtained, the mathematical equation of which was 
used to determine the approximate concentration of the culture in the subsequent experiments, using 
only the optical density. 
 
The accuracy of the mathematical function was validated by substituting the optical density of diluted 
overnight cultures and calculating the expected cell concentration. To establish the real cell 
concentration and validate the equation, the culture was also plated out on TSA after serial dilution. 
This was carried out each time mixed microbial overnight culture was used for an experiment and the 
data recorded. The % accuracy of the curve was then determined to ensure that the function was 
sufficiently accurate for use in MIC experimentation.  
	  
3.1.3) Yeast Culture Inoculum  
 
The recombinant yeast cultures hAR and hER were used in yeast screening assays. The two strains 
contain genes encoding the human androgen and human estrogen receptors, respectively. The presence 
of androgens (in the case of hAR) and estrogens (in the case of hER) result in binding of these compounds 
to the androgen or estrogen receptor which, in turn, results in the increased expression of β-galactosidase. 
The increased levels of this enzyme result in a colour change that can be quantified. The optical density 
of the yeast (at 600 nm) can also be compared with controls to determine the dose of methylparaben or 
carbamazepine that are cytotoxic to the yeast. The molecular mechanisms of this assay were discussed 
in greater detail in the literature review. 
 
A curve correlating the logarithm of optical density at 600 nm and the cell concentration was constructed, 
for both the hER and hAR strains of Saccharomyces cerevisiae, as was done for the CT07 pure bacterial 
culture above. The yeast medium was prepared, as described by Routledge and Sumpter (1996), by 
preparing 45 mL minimal medium (13.61 g KH2PO4; 1.98 g (NH4)2SO4, 4,2 g KOH, 0.2 g MgSO4; 1 mL  
0.5 mg.mL-1 Fe2(SO4)3; 50 mg L-histidine; 50 mg adenine; 20 mg L-arginine-HCl; 20 mg L-methionine; 
30 mg L-isoleucine; 30 mg L-lysine-HCl; 25 mg L-phenylalanine; 100 mg L-glutamate; 150 mg L-valine; 
375 mg L-serine; added to 1 L reverse osmosis water, autoclaved at 121oC for 15 minutes) in a sterile 50 
mL Erlenmeyer flask. To this, 5 mL 20% w/v glucose, 1.25 mL 4 mg.mL-1 aspartic acid, 400 µL 24 
mg.mL-1 threonine, 125 µL 20 mM copper sulphate solution and 500 µL vitamin solution was added. The 
vitamin solution comprised 4.44% (w/v) thiamine; 4.44% pyridoxine; 4.44% pantothenic acid; 22.22% 
inositol; 0.4% biotin dissolved in reverse osmosis water and filter sterilised. To this medium, 125 µL 
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yeast stock was added and incubated at 26oC in a shaking incubator overnight. Fresh medium was 
prepared the next day, and 1 mL of the yeast overnight culture was added for a second overnight 
incubation at 26oC. The yeast culture was diluted in the same manner as done for the CT07 strain and the 
dilutions were plated out and grown on solid yeast extract peptone dextrose (YPD) (Biolab, Merck) 
medium to obtain countable numbers.  
 
3.2) Effects of Micropollutants on Microbial Cultures 
 
The effects of carbamazepine and methylparaben on both the mixed microbial culture and CT07 strain were 
evaluated using minimum inhibitory concentrations (MICs). The effects of these micropollutants on 
recombinant yeast was also evaluated. The yeast assays evaluate both the endocrine disrupting potential of 
carbamazepine and methylparaben, as well as any potential lethal effects of these compounds on the yeast.  
 
3.2.1) Minimum Inhibitory Concentration Determinations 
 
MICs are assays that are used to determine the effects of potential antimicrobial compounds on a chosen 
bacterial strain.  Varying concentrations of a chosen compound are introduced to a consistent amount of 
bacterial cells in a series of test-tubes or wells to determine the concentrations at which the bacterial 
growth is inhibited. MIC assays were conducted in order to determine the inhibitory effects, if any, of 
carbamazepine and methylparaben on the mixed culture. The pure culture was used to determine a 
baseline effect of these compounds on a single strain, since the mixed culture contains multiple species 
and it was postulated that the mixed culture would show increased resistance to the effects of the 
compounds. 
 
3.2.1.1) Preparation of Micropollutant Dilutions 
 
The minimum inhibitory concentrations (MICs) of both carbamazepine and methylparaben were 
determined for both the mixed culture and pure culture (CT07), using an adaptation of the method 
described by Sabaeifard et al. (2014). Stock solutions of methylparaben (>99.0% purity, Sigma-
Aldrich®) and carbamazepine (>98% purity, Sigma-Aldrich®) were made at concentrations of 80 
g.L-1 and 40 g.L-1, respectively by dissolving the powdered forms in methanol. The concentration 
ranges tested were 74.5 ng.L-1 to 10 g.L-1, for both methylparaben and carbamazepine. A two-fold 
dilution series was set up across 28 wells in a 96-well microtitre plate in triplicate.  The concentration 
range was 74.5 ng.L-1 to 10 g.L-1 for both methylparaben and carbamazepine dilutions. Methylparaben 
dilutions were set up by placing 50 µL of methylparaben stock in the first well, and 25 µL absolute 
methanol in the subsequent 27 wells, transferring 25 µL of the methylparaben stock into the 
neighbouring well and mixing thoroughly until all 28 wells were diluted. Carbamazepine dilutions 
were set up in the same manner as was done for methylparaben, except the initial stock and methanol 
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volumes were doubled to 100 and 50 µL, respectively (transferring 50 µL across the wells) due to the 
fact that the carbamazepine stock was more dilute than that of methylparaben (due to lower solubility 
of carbamazepine in methanol than methylparaben). The microtitre plates were left under the sterile 
flow of the biological safety cabinet, with the lights off, until the methanol had completely evaporated, 
leaving only the dry compound in the wells.  
 
3.2.1.2) MICs 
 
Overnight cultures of the mixed and pure cultures were measured spectrophotometrically at 600nm 
using the Spectroquant® Pharo 300 spectrophotometer (Merck). The optical density reading was 
substituted into the respective equation, and the f(x) value was calculated to determine the estimated 
cell concentration. For example, for diluted CT07 overnight culture, the optical density of 0.052 at 
600 nm was measured and the value substituted for x: 
F(x) = 0.4955ln(x) + 9.4385 
        = 0.4955ln(0.052) + 9.4385 
        = 7.9735 à 107.9735 
        = 9.41 x 107 CFU.mL-1 
The volume of this culture required to make a 1 x 106 CFU.mL-1 in the final well volume of 200 µL 
was calculated to be 2 µL. The inoculum was also plated out and was determined to contain 2.9 x 106 
CFU.mL-1. 
A 10 g.L-1 sterile solution of TSB supplemented with 0.2% glucose was prepared and added to each 
well, with 200 µL in the negative control wells and 200 µL less the volume of overnight culture to 
the other wells. To the positive controls, only overnight culture was added to a final volume of 200 
µL. The overnight culture was then added to each well, the plates sealed with oxygen-permeable 
sterile film and incubated at 26oC in a shaking incubator for approximately 20 hours. The optical 
density of the plates was measured at 600 nm using an xMark™ Microplate Spectrophotometer 
(BioRad). Figure 3.2 demonstrates the placement of samples in the microtitre plates. 
 
	  
	  
	  
	  
	  
	  
	  
 Figure 3.2: Microtitre plate sample arrangement for MICs 
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3.2.1.3) Data Analysis 
 
The raw MIC data was analysed by subtracting the mean of the negative control optical densities from 
the mean of the optical densities for each concentration of the micropollutant being tested. The 
concentration range (in log ng.L-1) was calculated and plotted against the means of the differences 
between the optical density for each concentration less the negative control. This was done for both 
the carbamazepine and methylparaben MIC data.  
 
The standard error bars displayed at each point, were calculated using the formula:  
        σM =  σ  
                   √N 
where σM is the standard error of the mean; σ is the standard deviation of the data set and N is the 
number of data points in the data set (alternatively, the number of measurements in the population in 
the statistical vernacular). The standard error of the mean measures the degree of uncertainty, or 
variation, of the data around the mean (Samuels and Whitmer, 2003), in other words, it measures the 
degree of sampling error. 
 
3.2.2) Effect of Micropollutants on Recombinant Yeast  
 
Yeast screen assays, described by Routledge and Sumpter (1996), make use of recombinant yeast strains 
that possess a human receptor gene, as well as the receptor element the receptor binds to. In this case, the 
hER and hAR strains were used, the former possesses an estrogen receptor gene (the product of which is 
a regulatory protein that binds estrogen) as well as the element to which an estrogen receptor binds to 
upregulate beta galactosidase expression, which is present downstream of the element. The latter strain, 
hAR, is the same as hER except it contains an androgen receptor and its associated element. These assays, 
as described in detail in Section 2.2.1, quantitatively measure the amount of estrogen or androgen-
induced colour change, as a result of the presence of estrogenic or androgenic compounds in the growth 
medium. Therefore, they are used to quantify the endocrine disrupting potential of a test compound on 
the receptor the yeast expresses. The androgen assay was modified to create an anti-androgenic assay. 
This was done by adding a consistent concentration of an androgen (dihydrotestosterone (DHT)) to a 
range of carbamazepine concentrations, and measuring the lack of colour change (no colour change 
indicated a positive result: antagonism of the androgen receptor, or anti-androgenicity). The potential 
inhibitory effect of carbamazepine for the binding of androgens to the receptor was then evaluated. 
 
3.2.2.1)  Methylparaben Estrogenicity  
 
In order to establish the degree of estrogenic effect of methylparaben, a standard curve was established 
to correlate the degree of estrogenicity to a known estrogenic compound, 17β estradiol (E2). An 
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overnight culture of the hER strain was prepared the day before the assay, using the method discussed 
in section 3.2.1.  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
Flat-bottomed 96-well plastic microtitre plates were used for the yeast estrogen assay. A stock 
solution of methylparaben (100 g.L-1) was used to make a two-fold serial dilution in a separate 
microtitre plate from the ones used for the assay. The concentration range was 596 ng.L-1 to 5 g.L-1.  
This was done by adding 200 µL of the methylparaben stock solution to the first well of a row within 
the microtitre plate. To the subsequent 23 wells, 100 µL of HPLC-grade methanol (Sigma-Aldrich®) 
was added. Thereafter, 100 µL of the 200 µL methylparaben stock was transferred over to the well 
immediately adjacent to it. 100 µL was transferred across the wells until the dilution series was 
completed. 10 µL of the 24-well dilution series was transferred to wells C1-D12, E1-F12 and G1-H12 
of duplicate microtitre plates. A similar dilution series was made for E2 using only 12 wells and 30 µL 
of methanol diluent. 10 µL of this dilution series was transferred to wells A1-12 of both microtitre 
plates. 10 µL methanol was added to wells B1-12 of both plates, for the negative control. Figure 3.3 
is a schematic representation of the plate arrangement. The plates were placed in a biosafety cabinet, 
with the light off, until the methanol had evaporated completely. 
	  
The yeast medium was then prepared by adding 4 mL 20% w/v glucose, 1 mL 4 mg.mL-1 aspartic 
acid, 400 µL vitamin solution (see section 3.1.3), 320 µL 24 mg.mL-1 L-threonine, 100 µL 20 mM 
copper sulphate solution and 400 µL CPRG stock to 36 mL minimal medium (as described previously 
in section 3.1.3). The medium was filter sterilised to ensure complete removal of any possible 
contaminant microorganisms. 
 
The optical density (at 600 nm) of the hER overnight culture was measured and an appropriate volume 
of cell suspension added to seed it with 4.0 x107 cells. The seeded medium was then mixed thoroughly 
and a multichannel pipette was used to add 200 µL of the mixture to each well in both microtitre plates 
(aseptically, in a biological safety cabinet). The plates were covered and the sides sealed with tape to 
	  Figure 3.3: Yeast assay sample arrangement for methylparaben standard 
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prevent evaporation of the liquid medium during the incubation period. The plates were incubated at 
30oC until the colour change was sufficient (typically about 5 days). The optical density was measured 
at 540, 575 and 620 nm, after mixing through agitation, and the data analysed as shown in section 
3.2.2.3. 
 
3.2.2.2) Carbamazepine Anti-Androgenicity  
 
Carbamazepine, a recalcitrant compound, is suspected of exhibiting an anti-androgenic effect in 
higher organisms. In order to explore this, a standard curve was established to correlate the degree of 
anti-androgenicity of flutamide (a pharmaceutical with known anti-androgenic effects) with the 
suspected anti-androgenic compound (carbamazepine). 
 
An overnight culture of the strain was prepared as described in section 3.2.1. The carbamazepine anti-
androgen assay was done in a similar manner as the methylparaben estrogen assay, with slight 
modifications: 10 µL 16.67 µM dihydrotestosterone (DHT) solution (200 µL 100 µM DHT stock to 
1000 µL methanol) was added to every well in the microtitre plates except for the negative control 
wells (B1-6), as the test androgen which carbamazepine would antagonise. Then, a carbamazepine 
dilution series (596 ng.L-1 to 5 g.L-1 concentration range) was set up, using 50 g.L-1 stock. A volume 
of 20 µL 50 g.L-1 stock was added to the first wells (C1, E1 and G1) of both microtitre plates and a 
23-well doubling dilution series was prepared in a separate microtitre plate, in the same manner as for 
the methylparaben dilution above. A volume of 10 µL of the 23-well dilution series was added to the 
yeast microtitre plates (wells C2-D12, E2-F12 and G2-H12). A flutamide dilution series was made in 
exactly the same manner as the E2 dilution series above, and 10 µL from each well was added to wells 
A1-12 of both microtitre plates. Then, 10 µL methanol was added to wells B1-6 as a negative control 
(Figure 3.4). The plates were left under the flow of a biological safety cabinet until the methanol in 
each well was completely evaporated. The yeast assay medium was prepared as above, except that 
1.6 mL hAR overnight culture (OD600 = 0.8) was added to the assay medium. After the addition of 
200 µL seeded medium, the plates were covered and incubated at 30oC for 3 days. Readings of the 
plates were taken at 540, 575 and 620 nm. Data analysis is shown in section 3.2.5.  
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3.2.2.3)  Data Handling to Obtain Standard Curves 
 
The readings at 540 nm for each concentration must be subtracted from the reading at 620 nm for that 
same concentration, less the average for the blank:  
                                                  Acorrected = A540 – (A620 – Ablank),  
Where A represents the absorbance reading, and Ablank is the average of the blank readings. The 
negative control values were averaged for hER, and the positive control (without DHT, yellow wells) 
values were averaged for hAR, and these averages were used as the Ablank,. The calculations were done 
separately for individual concentrations for the separate replicates and then were ultimately averaged, 
to reflect each of the 6 separate data sets as one data set. There were 3 sets of technical repeats per 
plate, and two biological repeats (2 plates) per micropollutant. These analyses were done for 
methylparaben, carbamazepine and the two comparative standards, flutamide and estradiol. The 
standard error bars displayed at each point, were calculated using the formula:  
           σM =  σ  
                      √N 
 
3.3) Flow Cell Reactor  
3.3.1) Design and Construction 
 
A flow cell reactor was designed, the intention of which was to test whether the consumption of labile 
carbon sources by biofilm-bound microorganisms would lead to the metabolism of the remaining, 
recalcitrant carbon sources. This was achieved by extending the length of the reactor, by the insertion of 
silicone tubing (2 mm inner diameter) between two perspex flow cells (Wolfaardt et al., 1994), in order 
to increase both temporal and spatial exposure of sessile cells to the medium in the bulk aqueous phase. 
Next, sampling points were inserted at various positions of the reactor to obtain aqueous phase samples 
from. The original design used three-way stopcock connectors and silicon tubing with an inner diameter 
	  Figure 3.4: Yeast assay sample arrangement for carbamazepine standard 
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of 10 mm to facilitate ease of sampling, but required too much medium and too frequent medium changes 
to be feasible. The reactor sampling points were modified using small plastic T-pieces (2 mm inner 
diameter, 38 mm length and 21 mm height) (Cole-Parmer®) which were constructed from various plastic 
barbed connectors to serve as collection points. Silicone tubing with a smaller inner diameter (2 mm) 
was used to connect all the collection points. Silicone tubing is readily permeable to both oxygen and 
carbon dioxide (Kroukamp and Wolfaardt, 2009) thus allowing sufficient gaseous exchange to ensure 
that nutrient concentration be the dominant limiting factor and not oxygen availability.   
 
Flow cells (Wolfaardt et al., 1994) were incorporated into the system at the upstream and the downstream 
ends of the tube reactor, in order to visually evaluate the difference in the biofilms at either end of the 
reactor. Each flow cell channel was 31 mm long, 4.0 mm wide and 2.2 mm in depth (Bester, 2005). The 
completely constructed biofilm reactor, attached to the peristaltic pump is shown in Figure 3.5.  The flow 
rate in the system was 27 ml.h-1, leading to the displacement of the internal volume of each flow cell 
chamber (approximately 300 µL) every 40 seconds, and the entire reactor (3.5 mL) approximately every 
7 minutes (the times increased slightly proportional to the amount of biomass in the system). 
 
The samples tested in the reactor included either glucose or a micropollutants, or a combination of 
both. The sample types tested were as follows: 
(1) Glucose only (GLC), a control 
(2) Glucose and methylparaben (GMP) 
(3) Glucose and carbamazepine (GCBZ) 
(4) Methylparaben only (MP) 
(5) Carbamazepine only (CBZ) 
 
The samples, when referred to directly, will have been referred to as the abbreviated names in the rest of 
this thesis. The full names will sometimes have been used where the contents of the sample were referred 
to, and not the sample name itself. 
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Figure 3.5: Flow cell reactor  
The peristaltic pump (top left) pumped the blue fluid (used to enhance the visibility of the tubing) through 
the entire system from the beginning of the reactor (A) to the end of the reactor (E) and out of the system 
into a large Erlenmeyer flask used for waste collection (not pictured). The 4 collection points from which 
samples were collected throughout experimentation are labelled B, C, D and E for collection points 1, 2, 3, 
and 4, respectively. The lengths of tubing between collection points 1 and 2, 2 and 3, and 3 and 4 were each 
30 cm. 
	  
3.3.2) Optimisation  
 
The reactor was optimised according to the following final requirements: tubing diameter of 3mm and 
flow rate of 27 mL.h-1 that prevented excessive biomass accumulation (which caused large portions of 
biomass to detach from the biofilm, stopping the flow) without frequent medium changes (a 5 L flask of 
medium replaced every 3 days for duplicate samples). Numerous aspects of the physical system were 
altered, as well as the experimental conditions, over the optimisation process. The length, width and other 
physical parameters of the reactor were altered several times throughout the experimental process, in 
order to optimise the data collection and consumption of resources. Optimisation of experimental 
conditions included varying the flow rates, the types of growth medium and the types and concentrations 
of primary (labile) carbon sources. An initial flow rate of 15 mL.h-1 was chosen because it was the rate 
used for the perfusion column, but this was increased and set at 27mL.h-1 for the final experimentation 
parameters. M9 minimal medium was selected to ensure control over the type and concentration of 
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carbon source applied to the biofilms. The primary carbon sources were originally both glucose and 
lactose, because both could be enzymatically quantified and would support a wider range of microbes 
than just glucose alone. However, lactose was eventually removed in order to simplify the experiment as 
much as possible (using glucose only). Synthetic wastewater was tested as a growth medium, but since 
it contained amino acids which could be utilised as carbon and energy sources and resulted in blockages 
within the reactor due to the accumulation of large amounts of biomass, it it was not pursued in 
subsequent experimentation. The concentrations of the various carbon sources were chosen to reflect that 
which appears in the actual wastewater treatment system.  
 
The diagram of the entire reactor as well as the components, shown in Figure 3.5, represents the final 
(optimised) reactor system that was used.  
 
3.3.3) Operation of the Reactor 
 
Overnight cultures were prepared by dropping 3 biofilm-covered beads into 10 mL sterile glucose-
supplemented TSB and incubating at 26oC overnight. The reactor was sterilised by running a 20% NaOCl 
solution through the entire system for an hour. Sterile reverse osmosis water was then run through the 
system overnight. The next day, the M9 minimal medium (0.680% NaHPO4; 0.300% KH2PO4; 0.050% 
NaCl; 0.100% NH4Cl; 0.024% MgSO4 and 0.001% CaCl2) was prepared and the appropriate nutrient 
sources were added, depending on the test being performed: 0.06% glucose; 1000 ng.L-1 methylparaben 
and 600 ng.L-1 carbamazepine, to reflect those concentrations found in environmental samples. The 
medium was then pumped through the reactor to rinse out the water and then the pump was stopped.  
 
The optical density of the overnight culture was measured and subsequently diluted, immediately before 
inoculation, in saline in order to adjust it to OD600 of 0.1. The diluted inoculum was injected into the 
reactor at the upstream end of the reactor (collection point 1 in Figure 3.5), using a syringe and 22-gauge 
needle, until the system was completely filled (about 3.5 mL). The inoculum was left to adhere for 30 
minutes, after which the peristaltic pump was switched on. The entire reactor was then kept in the dark, 
to prevent growth of algae and other phototrophs, for the duration of experimentation, which was 6 days. 
 
3.4) Reactor Experimentation 
3.4.1) Microscopy 
3.4.1.1) Light Microscopy  
 
The biofilms attached to the glass coverslips of the flow cells were observed, in real-time, using a 
UB202i light microscope (UOP™) fitted with a 5.0 megapixel (MP) DCM500 USB 2.0 CMOS chip 
camera. The ScopePhoto x64 (Scopetek) freeware was used to capture real time images and video	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footage of the biofilms. The biofilms were mostly observed, photographed and filmed at the 100x oil 
immersion objective magnification.  
 
3.4.1.2) Confocal Laser Scanning Microscopy (CLSM) 
 
Preparation of Samples  
 
After the 6-day incubation period, the two flow cells at the upstream and downstream ends were 
sacrificed for CLSM analysis. The peristaltic pump was turned off and 300 µL of a Baclight™ 
Live/Dead (ThermoFisher Scientific) dye solution (0.2% SYTO®9; 0.2% propidium iodide) was 
injected slowly into the flow cell chambers using a sterile 1 mL syringe and a 26-gauge sterile 
needle. The flow cells were then incubated in dark conditions for up to 45 minutes, depending 
on the thickness of the biofilm. The pump was switched back on (set to the same flow rate) for 
10 to 15 minutes to allow the residual dye to be completely flushed from the system. The pump 
was then switched off again, and the connectors for each chamber from the downstream side 
were clamped off and removed carefully, and the silicone tubing within the outlets were 
obstructed (using marine silicone (Bostik®)) to retain the fluid inside the channel of the flow 
cells. The tubing upstream of the flow cell chambers were then clamped and removed for each 
chamber, tilting the open side of the flow cell upwards to prevent loss of the fluid within the 
chambers. These inlets were then also sealed, and the flow cells were cleaned with 70% ethanol, 
wrapped in aluminium foil and placed in a dark container for transport to the microscope.  
 
Obtaining Image Stacks  
 
The CLSM data was obtained in the form of Z-image stacks, which are a type of file containing 
multiple images. The file type in which the stacks were saved was an LSM 5 file with the 
extension “.lsm”. The images were obtained using an LSM780 with ELYRA S.1 Superresolution 
Platform Confocal Microscope (Zeiss), with lasers set to 2 tracks: 488 and 561 nm corresponding 
to green and red fluorescence of the BacLight components, respectively. A total of 9 image stacks 
were obtained in the Z-direction of duplicate flow cell channels for each variable (GLC, GMP, 
etc.) using an oil-immersion 40X objective, starting at the biofilm attached to the glass coverslip 
and extending into the biofilm.  The resolution of each image in the stack was 1024 x 1024 pixels, 
saved in dual channels (red and green). The dimensions of the stacks were 212.55 µm square (x 
and y). The depth of the stack varied per sample, as the thickness of each Z-stack was adjusted 
according to the thickness of the biofilm in each sample. 
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Data Analysis  
 
Biofilm analysis was done using the COMSTAT script (Heydorn et al., 2000) written for the 
Matrix Laboratory (MATLAB®) software (The MathWorks Inc.), while qualitative image 
analyses were done using ImageJ software or Adobe® Photoshop.  
 
The MATLAB® software requires the image stacks to be in a specific format. Each image stack 
must be separated into the separate image layers, in .TIF format. Each .lsm file (containing the 
image stack) was converted in to its constituent images using Zen Lite 2012 software (Zeiss™). 
Each .lsm file was exported from Zen Lite and each image slice saved as separate .TIF files 
within an appropriately named folder. The image (and supporting info files) data analysis was 
done according to the protocol provided in Heydorn et al. (2000) as well as the operational 
manual provided with COMSTAT (upon request to the author, Arné Heydorn).  
 
Each image set (stack of images) was analysed and converted into 6 separate data sets: 
(1) average biofilm thickness (µm) 
(2) maximum biofilm thickness (µm) 
(3) biomass (µm3/µm2) 
(4) substratum coverage (%) 
(5) roughness coefficient (Ra*) 
(6) surface area to biovolume ratio (µm2/µm3) 
 
The term ‘biomass’ describes the volume of space occupied by the biofilm compared to the 
surface area covered. Substratum coverage refers to the proportion of the glass surface that was 
covered with biofilm within the visible field of the microscope image. Roughness coefficient 
(Ra*) is a measure of heterogeneity of the biofilm (Heydorn et al., 2000). It is a dimensionless 
measurement that was suggested by Murga et al., (1995), and it describes the surface topography 
of the biofilm. Surface area to biovolume ratio, simply put, describes the amount of surface area 
per unit volume. What it actually describes is the absorptive potential of the object, based on its 
surface area and volume (Blamire, 2001). A larger ratio means a greater absorptive potential of 
the surface of the biofilm, which is of importance in nutrient availability. 
 
The data was analysed using one-way analysis of variance (ANOVA), with a P value of 0.05. 
ANOVA tests whether one population (or data set) is the same as another: this is called the null 
hypothesis. The ANOVA analysis returns an F value and a P value. The F value must be higher 
than the Fcrit value (provided during the analysis), and the P value returned must be smaller than 
0.05 for the null hypothesis to be rejected. Statistical programs were available for ANOVA 
analysis, but it was preferred to analyse the data in Microsoft Excel® using a plugin (installed 
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separately) that specifically allowed ANOVA analyses. There were 9 data points per data set, 
where one data set was one category of one sample type (i.e. glucose upstream average thickness 
was one data set, while glucose downstream average thickness was a second data set, glucose 
upstream maximum thickness a third, etc.). Each category was only compared with other samples 
within the same category and the sample types were only compared when they had one carbon 
source in common. Upstream categories were only compared with upstream categories, and 
downstream with only downstream. For example, the average thicknesses of GLC upstream and 
GMP upstream were compared, but not the average thicknesses of GLC upstream and GMP 
downstream, or GLC upstream and MP upstream.  
 
3.4.2) Secondary Carbon Source (Micropollutant) Analysis 
 
Liquid chromatography mass spectrometry (LCMS) was performed on samples from the reactor, as well 
as the medium that was being pumped into the reactor, in order to determine if, and to what degree, the 
micropollutants were being degraded. The samples containing glucose and those that did not were 
compared to determine if the presence of glucose affected the degradation of the secondary carbon 
sources (the micropollutants: methylparaben and carbamazepine). 
 
3.4.2.1) Fate of Secondary Carbon Sources (Micropollutants) in the Reactor 
 
Raw samples were extracted from the reactor after the 6-day incubation period and concentrated using 
solid phase extraction (SPE). Samples from the downstream end of the reactor (collection point 4 in 
Figure 3.5) were collected in 20 mL volumes, in sterile 50 mL Falcon tubes, using the same flow rate 
as what is used to run the medium during normal incubation. With a flow rate of 27 mL.h-1, collection 
of at least 20 mL for solid phase extraction took approximately 45 minutes. The longer waiting period 
for the sample to reach sufficient volume necessitated keeping the samples on ice to reduce further 
bacterial degradation of the micropollutant. Once enough of the sample was collected, the samples 
were centrifuged at 3 000 rpm for 10 minutes to pellet the biomass. The supernatant was collected 
and kept on ice until processing.  
 
A 12 slot manifold (Supelco™, Sigma) was set up with a -5 mmHg vacuum (1 mL.min-1 flow rate) 
and, for each sample to be extracted, a 3 mL (60 mg) hydrophillic-lipophillic balance (HLB) SPE 
column (Supelco™ Sigma-Aldrich®) was placed into one of the 12 manifold slots and labelled 
according to the sample to be extracted. The exterior of each of the columns was wrapped in 
aluminium foil to prevent UV degradation of the samples during processing. A volume of 3 mL 
HPLC-grade methanol (Sigma-Aldrich®) was drawn through each column, and thereafter 3 mL 
Millipore water. Care was taken to close the taps of the manifold so that a very small meniscus of 
water was still covering the adsorptive material within the columns. This served to prevent drying of 
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the material after conditioning, which would have rendered the adsorptive material less effective in 
binding the compounds for analysis. 
 
 Each of the samples, kept on ice in the interim, was pushed through a 0.22 µM cellulose-acetate 
syringe filter (Amtast™) to remove all cellular material and polysaccharides before being drawn 
through their respective HLB columns at 1 mL.min-1. Once the samples had completely passed 
through the columns, the HLB adsorptive materials were completely dried out, wrapped in foil and 
frozen in airtight package at -20oC until a week before sample submission, in order to preserve the 
structure of the compounds contained within them. 
 
The frozen columns were thawed and eluted into HPLC-grade (99.9% purity) methanol (Sigma-
Aldrich®). Once thawed, the columns were placed into the slots in the manifold. The samples were 
eluted out of the column using 3 mL HPLC-grade methanol, per sample, in pyrolysed, borosilicate 
glass test tubes. The methanol in each tube was evaporated completely, in the dark using nitrogen gas 
with clean borosilicate glass Pasteur pipettes fixed onto the gas distribution head. Once each tube was 
completely dry, the sample was re-suspended in 200 µL HPLC-grade methanol and vortexed 
rigorously to ensure the highest amount of resuspension possible. Each sample, now concentrated to 
200 µL, was transferred to a 200 µL pyrolysed borosilicate glass vial insert (Stargate Scientific) 
placed within a 2 mL amber glass vial and sealed tightly with a polypropylene cap possessing a PTFE 
seal. The samples were stored at -20oC until submission for analysis, or for use in the yeast screens.  
 
Each time samples were submitted for mass spectrometry, a set of standard concentrations for each 
analyte was prepared. These standards ranged in concentration from 1ppm (mg.L-1) to 10 ppt (ng.L-
1). The analysis was done using an Acquity UPLC® Mass Spectrometer using 0.1% formic acid and 
9:1 solution of water and acetonitrile.  
 
The data acquired from the mass-spectrometer were analyses using ANOVA, with a P value of 0.05. 
The influent and effluent concentrations were also included in Table 4.2, along with the standard error 
(of the mean). The percentage removal (referred to as removal efficiency in the table) was also 
calculated and included in Table 4.2. ANOVA and standard error calculations were also conducted 
on the removal efficiencies (shown in Table 4.2). 
 
3.4.2.2) Endocrine-Disrupting Effects of Reactor Samples 
 
The samples prepared for mass spectrometry were used in yeast assays to determine if the 
concentration of the micropollutants in the reactor, taken on day 6 of the reactor runs, (concentrations 
corresponding to those reported for WWTPs: methylparaben at 1000 ng.L-1 and carbamazepine at 
600ng.L-1 (Archer et al., 2017) were capable of eliciting any endocrinologic effects on the receptors 
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the  recombinant yeast. The concentrated samples which contained carbamazepine were subject to an 
anti-androgenic assay (using hAR strain) while those which contained methylparaben were subject to 
an estrogen assay (using hER strain).  
 
Samples were collected from the downstream end of the flow cell reactor (collection point 4 in Figure 
3.5) supplied with M9 minimal medium supplemented with 1000 ng.L-1 methylparaben or 600 ng.L-1 
carbamazepine (with or without glucose, depending on the sample type) and concentrated 100X (as 
described in section 3.4.3.1). The estrogen yeast assay was prepared by making an E2 dilution series, 
as described in section 3.2.2.1. The concentrated samples were placed into the microtitre plates in 20, 
10 and 5 µL volumes (10X, 5X and 2.5X concentrations of the original 100X concentrated samples) 
in duplicate for both the estrogen and anti-androgen assay.  The samples were allowed to evaporate 
completely before the addition of 200 µL assay medium, seeded with the appropriate strain of yeast 
(hER for estrogen assay and hAR for anti-androgen assay, respectively). The plates were incubated 
at 30oC until undergoing an adequate degree of colour change. Readings were taken at 540 and 620 
nm and the data processed as described in section 3.2.2.3.  
 
3.4.3) Primary Carbon Source (Glucose) Analysis 
 
Glucose analysis was conducted on the reactor samples in order to determine the degree of glucose 
depletion due to microbial metabolism at various spatial distributions across the reactor. Glucose was the 
primary (more labile) nutrient source and it was postulated that the depletion of glucose would occur at 
a certain point within the reactor to the degree where the microbes downstream would be forced to use 
the micropollutant as a carbon source.  
 
Approximately 1 mL of bulk-liquid was sampled from each collection point and the samples were 
centrifuged at 8 500 rpm for 15 minutes in a table top microfuge. The supernatant was aliquotted into 
sterile Eppendorf tubes (approximately 1 mL volume per sample). Standard glucose solutions of 500 
mg.L-1 and 800 mg.L-1 were made for each set of samples. The tubes were then kept frozen at -20oC until 
submission for enzymatic analysis. Duplicates of replicate test were collected and the standard error (of 
the mean) was calculated for each set of replicates (data point on the graph), using the equation provided 
earlier. 
 
3.4.4) Planktonic Cell Release 
 
Planktonic cell counts were performed on samples collected daily from the downstream effluent end of 
the reactor (collection point 4 in Figure 3.5), until a steady-state was reached (consistent cell 
concentrations in the collected effluent samples). Thereafter, cell counts were taken from each of the 4 
collection points, on day 6, in duplicate. Cell count data was obtained by collecting 1 mL of effluent in a 
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sterile 1.5 mL Eppendorf tube from the respective sampling points, after clamping off the part of the 
reactor directly downstream of the point from which effluent was taken. The clamp was removed and 
100 µL of the effluent in the tube was subjected to a 10-fold dilution series in sterile saline and plated 
onto solid M9 minimal medium (0.06% glucose, 1.2% agar). The plates were incubated for 48 hours at 
26oC, after which the colonies were enumerated and recorded.  
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Chapter 4: Results 
 
4.1) Microbe-Micropollutant Interactions 
 
The effects of methylparaben and carbamazepine on microbial growth and biofilm formation were 
investigated. The possible endocrine-disruption potential of these two compounds on yeast expressing 
human estrogen and androgen receptors was also determined. Lastly, the effects of these compounds on 
physical structure of the biofilm was investigated in order to ascertain how the presence of these 
compounds can alter biofilm structure (and perhaps function, by extension). 
 
4.1.1) Microbial Inhibitory Effects of Methylparaben and Carbamazepine 
 
The inhibitory effects of methylparaben on the growth of the CT07 culture and the mixed microbial 
culture are shown in Figure 4.1. The graph shows the optical density of the culture with increasing 
concentrations of methylparaben (in log ng.L-1). The functions for best-fit trend lines as well as the the 
R2 values are shown below the curves. Due to the erratic nature of the mixed MIC curve, a best-fit curve 
was included (called MIC modified) in order to mathematically estimate the MIC value (since the 
concentration range was not high enough in the experimental design for it to be represented on the 
original curve.	  
Figure 4.1: MIC of methylparaben for both CT07 and mixed microbial cultures 
The MIC of methylparaben for CT07 and the mixed microbial culture are represented by the green and purple 
curves, respectively. Best-fit curves are represented by the dotted lines (green for CT07 and blue for the mixed 
microbial culture), with their R2 values and equations shown in the corresponding colour. The MICs were 
measured at an optical density of 600 nm. The error bars represent the standard error of the mean for each point. 
y = 0.0016x4 - 0.042x3 + 0.36x2 - 1.191x + 2.3217
R² = 0.96107
y = -0.0007x4 + 0.0139x3 - 0.1066x2 + 0.3544x - 0.0372
R² = 0.99486
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It must also be pointed out that the mixed microbial culture did not reach the same maximum optical 
density within 20 hours as the pure culture did. In order to maintain consistency, however, the same 
experimental parameters (incubation time) had to be applied to both CT07 and the mixed culture. The 
optical density of the CT07 and mixed microbial cultures after 20 hours was 1.06 and 0.42, respectively. 
The optical density of the negative control was 0.052 for both cultures.  
 
The optical density of the CT07 culture at log 10 ng.L-1 (10 g.L-1) was 0.055, which indicated 95% 
growth inhibition. The MIC of methylparaben for CT07 was therefore slightly higher than 10 g.L-1, 
and was mathematically determined to be 10.6 g.L-1 by extrapolating the curve. The optical density at 
10 g.L-1 (0.055) and the optical density required for complete growth inhibition (0.052) were used to 
estimate the concentration of methylparaben at 0.052 using a simple ratio equation.  The optical density 
of the mixed microbial culture at 10 g.L-1 was 0.258: only 44% growth inhibition. Therefore, the MIC 
of methylparaben for the mixed microbial culture was notably higher than 10 g.L-1, and was 
mathematically estimated to be around 256.7 g.L-1, based on the equation: 
                   M =  y2 – y1  
                             x2 – x1 
where M is the gradient of the curve and the x and y values refer to two coordinates on the curve. The 
last two points on the MIC (Modified) curve (blue curve) were used to calculate the gradient of that 
part of the curve and this gradient was then used to calculate the x value when y was 0.052 (the optical 
density at which the MIC occurred) if the curve had been extrapolated to cross the x-axis. 
 
The MIC data of carbamazepine for both the CT07 and mixed microbial cultures is presented in Figure 
4.2. Differences in maximum optical density were also seen with carbamazepine MIC assay (1.08 and 
0.38 for CT07 and the mixed culture, respectively). The negative control for both cultures was 0.051. 
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Figure 4.2: MIC of carbamazepine for both CT07 and mixed microbial cultures 
The MIC of carbamazepine for CT07 and the mixed microbial culture are represented by the green and purple 
curves, respectively. The MICs were measured at an optical density of 600 nm and the error bars represented the 
standard error of the mean for each concentration of carbamazepine. 
 
4.1.2) Potential Endocrine-Disrupting Effects of Methylparaben and Carbamazepine 
 
Two recombinant Saccharomyces cerevisiae strains were used to reveal possible physiological 
responses, caused by methylparaben and carbamazepine, in human endocrine systems. Figure 4.3 
contains the data for the yeast estrogen assay, while Figure 4.4 contains the data for the yeast anti-
androgen assay. Due to the fact that the anti-androgen assay was a reversal of the normal estrogen/ 
androgen assay, the negative and positive controls were reversed, since the yellow medium in the 
anti-androgenicity assay would have indicated a positive response (inhibition of the androgen) while 
red/purple medium indicated a lack of anti-androgenic effect. The colour of the medium for the 
positive control in the anti-androgen assay and the negative control in the estrogen assay remained 
the same and each was used to calculate the corrected absorbance values seen in the y-axis of the 
curves in Figures 4.3 and 4.4.  
 
Figure 4.3 shows the standard curve for estradiol, used as the estrogenic standard against which 
methylparaben was compared. The ED50 marker represents the point at which 50% of the maximum 
estrogenic effect is seen.  The results show that methylparaben has a low-to-moderate potent 
estrogenic effect, as the estrogen receptor agonism occurs only at methylparaben concentrations 
upwards of 19.5 mg.L-1. The portion of the curve in figure 4.3 that intersected with the negative 
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control line was the point at which the yeast cells were completely killed by methylparaben (1.58 g.L-
1) Figure 4.4 shows the results of the anti-androgenic yeast assay with the hAR strain. Flutamide, the 
standard, showed the expected sigmoidal shape. The carbamazepine curve showed that anti-
androgenic effects, or androgen receptor antagonism, occurred at concentrations above 776 µg.L-
1. The carbamazepine curve fluctuated after the initial exponential decrease. It was expected that the 
curve would continue in an exponential decrease, much like that of flutamide, but the curve inflected 
and fluctuated to an eventual, but gradual, decrease. The anti-androgenic point was taken to be where 
the initial decrease occurred:  6.087 on the x-axis (776 µg.L-1). 
 
 
Figure 4.3: Estrogenicity data for methylparaben for the hER strain of yeast 
The figure depicts the estrogenicity curves for both estradiol and methylparaben. The blank reading for the assay 
has been depicted as the line y = 1.223. The error bars indicate the standard error of the mean for each 
concentration of either methylparaben or estradiol. 
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Figure 4.4: Anti-androgenicity data for carbamazepine for the hAR strain of yeast 
The positive and negative blank reading for the assay have been represented as the lines y = 0.866 and y = 1.609, 
respectively. The latter represents colour change as a result of androgenicity of DHT, while the former represents 
the result of complete inhibition of the androgen. The error bars indicate the standard error of the mean for each 
concentration of either carbamazepine or flutamide. 
 
4.1.3) Effects of Micropollutants on Biofilm Structure 
 
4.1.3.1) Light Microscopy 
 
The flow cells, situated in the upstream and downstream ends of the reactor, provided an ideal means 
to evaluate the development of the biofilm in real-time. Light microscopy was conducted by viewing 
the glass-covered surface of the flow cells, both upstream and downstream of the reactor, at 1000X 
(using a 100X oil-immersion lens). Still images were taken of the biofilm using the attached 
microscope camera (2 megapixels), which allowed for qualitative analysis of the biofilm in real-
time, in order to ascertain what effects, if any, occur within the biofilm as a result of position 
(upstream vs downstream) and presence/absence of the compound. Figure 4.5 shows a colour plate 
of with representative images of the biofilm of each sample (20+ images for each sample GLC, 
GMP. MP. GCBZ and CBZ).  
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Figure 4.5: Light micrographs taken of the respective biofilms attached to the glass surface in the flow cells.  
The images on the left depict the biofilms from the flow cell located upstream of the reactor while the images on the 
right depict the biofilms downstream. A-B: Glucose only (GLC); C-D: Glucose and methylparaben (GMP); E-F: Glucose 
and carbamazepine (GCBZ); G-H: Methylparaben only (MP); I-J: Carbamazepine only (CBZ). 
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4.1.3.2) Confocal Laser Scanning Microscopy (CLSM) 
 
The image stacks were processed an analysed as described in the methods section. The physical 
characteristics of the biofilms are shown in Figure 4.6 and 4.7, with the corresponding ANOVA 
results and T-Test analyses presented in Table 4.1. 
 
 The images obtained from the image stacks were layered over one another using Adobe Photoshop, 
to obtain a topographical view of each biofilm. For illustration, these images are shown (for each 
sample type) in Figure 4.8. The MATLAB® analysis yielded thematic maps of the biofilm, where 
the degree of colour indicated the depth of the biofilm. These maps are shown in Figure 4.9.  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
Figure 4.6: Surface coverage of the biofilms of different samples for confocal data (in %) 
 
The substratum (surface) coverage of the glass coverslips of the biofilm is shown in percentage surface 
coverage. The error bars represent the standard error of the mean, calculated for the mean of each sample 
type. Data for the upstream flow cell is shown in green, while that of the downstream is shown in purple. 
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Table 4.1 ANOVA analysis of the confocal data 
The column on the left shows the samples that are compared with the samples on the top of the table. A “O” indicates no 
rejection (the two samples compared were statistically similar). An “X” indicates that the null hypothesis is rejected (the two 
samples are considered statistically different. 
Test	  Sample	  
Parameter	  
(ANOVA	  /	  T-­‐Test)	  
Glucose	  Only	   Glucose	  and	  Methylparaben	  	   Methylparaben	  
Glucose	  and	  
Carbamazepine	  	   Carbamazepine	  	   ALL	  
Up	  
stream	  
Down	  
stream	  
Up	  
stream	  
Down	  
stream	  
Up	  
stream	  
Down	  
stream	  
Up	  
stream	  
Down	  
stream	  
Up	  
stream	  
Down	  
stream	  
Up	  
stream	  
Down	  
stream	  
Average	  Thickness	  (μm)	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
	  	   Glucose	  
Only	  
UP	   	  	   	  	   O	   	  	   	  	   	  	   O	   	  	   	  	   	  	  
X	   X	  
	  	   DOWN	   	  	   	  	   	  	   O	   	  	   	  	   	  	   X	   	  	   	  	  
	  	   Glucose	  
and	  MP	  
UP	   O	   	  	   	  	   	  	   X	   	  	   O	   	  	   	  	   	  	  
	  	   DOWN	   	  	   O	   	  	   	  	   	  	   X	   	  	   X	   	  	   	  	  
	  	  
MP	   UP	  
	  	   	  	   X	   	  	   	  	   	  	   	  	   	  	   O	   	  	  
	  	   DOWN	   	  	   	  	   	  	   X	   	  	   	  	   	  	   	  	   	  	   X	  
	  	   Glucose	  
and	  CBZ	  
UP	   X	   	  	   O	   	  	   	  	   	  	   	  	   	  	   X	   	  	  
	  	   DOWN	   	  	   X	   	  	   X	   	  	   	  	   	  	   	  	   	  	   X	  
	  	   CBZ	   UP	  
	  	   	  	   	  	   	  	   O	   	  	   X	   	  	   	  	   	  	  
	  	   DOWN	   	  	   	  	   	  	   	  	   	  	   X	   	  	   X	   	  	   	  	  
Maximum	  Thickness	  (μm)	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
	  	   Glucose	  
Only	  
UP	   	  	   	  	   O	   	  	   	  	   	  	   X	   	  	   	  	   	  	  
X	   X	  
	  	   DOWN	   	  	   	  	   	  	   O	   	  	   	  	   	  	   X	   	  	   	  	  
	  	   Glucose	  
and	  MP	  
UP	   O	   	  	   	  	   	  	   X	   	  	   O	   	  	   	  	   	  	  
	  	   DOWN	   	  	   O	   	  	   	  	   	  	   X	   	  	   X	   	  	   	  	  
	  	   MP	   UP	  
	  	   	  	   X	   	  	   	  	   	  	   	  	   	  	   O	   	  	  
	  	   DOWN	   	  	   	  	   	  	   X	   	  	   	  	   	  	   	  	   	  	   X	  
	  	   Glucose	  
and	  CBZ	  
UP	   X	   	  	   O	   	  	   	  	   	  	   	  	   	  	   X	   	  	  
	  	   DOWN	   	  	   X	   	  	   X	   	  	   	  	   	  	   	  	   	  	   X	  
	  	   CBZ	   UP	  
	  	   	  	   	  	   	  	   O	   	  	   X	   	  	   	  	   	  	  
	  	   DOWN	   	  	   	  	   	  	   	  	   	  	   X	   	  	   X	   	  	   	  	  
Biomass	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
	  	   Glucose	  
Only	  
UP	   	  	   	  	   O	   	  	   	  	   	  	   O	   	  	   	  	   	  	  
X	   X	  
	  	   DOWN	   	  	   	  	   	  	   O	   	  	   	  	   	  	   X	   	  	   	  	  
	  	   Glucose	  
and	  MP	  
UP	   O	   	  	   	  	   	  	   X	   	  	   O	   	  	   	  	   	  	  
	  	   DOWN	   	  	   O	   	  	   	  	   	  	   X	   	  	   X	   	  	   	  	  
	  	   MP	   UP	  
	  	   	  	   X	   	  	   	  	   	  	   	  	   	  	   X	   	  	  
	  	   DOWN	   	  	   	  	   	  	   X	   	  	   	  	   	  	   	  	   	  	   X	  
	  	   Glucose	  
and	  CBZ	  
UP	   O	   	  	   O	   	  	   	  	   	  	   	  	   	  	   X	   	  	  
	  	   DOWN	   	  	   X	   	  	   X	   	  	   	  	   	  	   	  	   	  	   X	  
	  	  
CBZ	   UP	  
	  	   	  	   	  	   	  	   X	   	  	   X	   	  	   	  	   	  	  
	  	   DOWN	   	  	   	  	   	  	   	  	   	  	   X	   	  	   X	   	  	   	  	  
Roughness	  Coefficient	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
	  	   Glucose	  
Only	  
UP	   	  	   	  	   X	   	  	   	  	   	  	   O	   	  	   	  	   	  	  
X	   X	  
	  	   DOWN	   	  	   	  	   	  	   O	   	  	   	  	   	  	   X	   	  	   	  	  
	  	   Glucose	  
and	  MP	  
UP	   X	   	  	   	  	   	  	   X	   	  	   O	   	  	   	  	   	  	  
	  	   DOWN	   	  	   O	   	  	   	  	   	  	   X	   	  	   X	   	  	   	  	  
	  	   MP	   UP	  
	  	   	  	   X	   	  	   	  	   	  	   	  	   	  	   X	   	  	  
	  	   DOWN	   	  	   	  	   	  	   X	   	  	   	  	   	  	   	  	   	  	   X	  
	  	   Glucose	  
and	  CBZ	  
UP	   O	   	  	   O	   	  	   	  	   	  	   	  	   	  	   X	   	  	  
	  	   DOWN	   	  	   X	   	  	   X	   	  	   	  	   	  	   	  	   	  	   X	  
	  	   CBZ	   UP	  
	  	   	  	   	  	   	  	   X	   	  	   X	   	  	   	  	   	  	  
	  	   DOWN	   	  	   	  	   	  	   	  	   	  	   X	   	  	   X	   	  	   	  	  
Substratum	  Coverage	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
	  	   Glucose	  
Only	  
UP	   	  	   	  	   X	   	  	   	  	   	  	   X	   	  	   	  	   	  	  
X	   X	  
	  	   DOWN	   	  	   	  	   	  	   O	   	  	   	  	   	  	   X	   	  	   	  	  
	  	   Glucose	  
and	  MP	  
UP	   X	   	  	   	  	   	  	   X	   	  	   X	   	  	   	  	   	  	  
	  	   DOWN	   	  	   O	   	  	   	  	   	  	   X	   	  	   X	   	  	   	  	  
	  	   MP	   UP	   	  	   	  	   X	   	  	   	  	   	  	   	  	   	  	   X	   	  	  	  	   DOWN	   	  	   	  	   	  	   X	   	  	   	  	   	  	   	  	   	  	   X	  
	  	   Glucose	  
and	  CBZ	  
UP	   X	   	  	   X	   	  	   	  	   	  	   	  	   	  	   X	   	  	  
	  	   DOWN	   	  	   X	   	  	   X	   	  	   	  	   	  	   	  	   	  	   X	  
	  	  
CBZ	   UP	  
	  	   	  	   	  	   	  	   X	   	  	   X	   	  	   	  	   	  	  
	  	   DOWN	   	  	   	  	   	  	   	  	   	  	   X	   	  	   X	   	  	   	  	  
Surface	  Area	  to	  Volume	  Ratio	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
	  	   Glucose	  
Only	  
UP	   	  	   	  	   X	   	  	   	  	   	  	   X	   	  	   	  	   	  	  
X	   X	  
	  	   DOWN	   	  	   	  	   	  	   O	   	  	   	  	   	  	   X	   	  	   	  	  
	  	   Glucose	  
and	  MP	  
UP	   X	   	  	   	  	   	  	   O	   	  	   O	   	  	   	  	   	  	  
	  	   DOWN	   	  	   O	   	  	   	  	   	  	   X	   	  	   X	   	  	   	  	  
	  	   MP	   UP	   	  	   	  	   O	   	  	   	  	   	  	   	  	   	  	   X	   	  	  	  	   DOWN	   	  	   	  	   	  	   X	   	  	   	  	   	  	   	  	   	  	   X	  
	  	   Glucose	  
and	  CBZ	  
UP	   X	   	  	   O	   	  	   	  	   	  	   	  	   	  	   X	   	  	  
	  	   DOWN	   	  	   X	   	  	   X	   	  	   	  	   	  	   	  	   	  	   X	  
	  	   CBZ	   UP	   	  	   	  	   	  	   	  	   X	   	  	   X	   	  	   	  	   	  	  
	  	   DOWN	   	  	   	  	   	  	   	  	   	  	   X	   	  	   X	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Figure 4.8: Confocal images (in RGB colour) created by slice overlaying (this page and previous page) 
The images, starting from A and ending at J, are all image slices that were layered over one another to form the full stack. 
In other words these photos are 3D (x, y and z axes). Images on the left show the upstream flow cell, while images on the 
right show the downstream flow cell. A-B = glucose only samples (control samples); C-D  = glucose and methylparaben 
samples; E-F = glucose and carbamazepine samples; G-H = methylparaben only samples, I-J = carbamazepine only 
samples. All images are at 63X magnification, with no optical zoom. 
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Figure 4.9: Colour intensity (thematic) maps for the biofilms of the confocal data of the different samples  
The images in this plate represent the topographical structure of the biofilms of the various samples where A-B = glucose only; 
C-D = glucose and methylparaben; E-F = glucose and carbamazepine; G-H = methylparaben only; I-J = carbamazepine only. 
The colour variation is indicative of the thickness of the biofilm. Colour intensity keys are provided on the right, and are measured 
in µm. 
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4.2) Influence of Flow Cell Reactor Design on the Assimilation of Carbon Sources and Adhered 
Biofilms 
 
4.2.1) Spatial Gradient of Carbon Sources  
 
The concentrations of the carbon sources were measured with distance through the reactor. Figure 4.10 
shows the depletion of glucose throughout the reactor (measured at the different collection points of the 
reactor). The concentrations of the secondary carbon sources (methylparaben and carbamazepine) were 
evaluated using LCMS. The standards and blanks of the LCMS data were not accurate, often returning 
values much higher than what was added, and the blank samples (with only pure methanol) would return 
with high amounts of micropollutant. Therefore, only the differences between influent and effluent are 
shown (relative concentration change). Table 4.2 shows the standard error of the influent and effluent 
concentrations and removal efficiencies of both methylparaben and carbamazepine-containing samples 
in the flow cell reactor. 
 
Figure 4.10: Spatial reduction of glucose throughout the reactor 
 
The graph represents the reduction of glucose concentration for the samples that contained glucose (GLC, GMP 
and GCBZ). The error bars represent the standard errors of the mean (for each data point of which there were 3 
or 4 replicates, depending on the usable data). 
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Table 4.2: Mass-spectrometry data (and statistical analysis) of secondary carbon sources 
	  
	  
	  
	  
	  
	  
4.2.2) Endocrine-Disrupting Potential of Effluent from the Reactor 
 
The results of the yeast screen tests are shown in Table 4.3. The samples contained levels of 
micropollutants that are representative of what is present in the environment (in WWTPs and effluent 
from WWTPs).  The data is displayed in a qualitative manner, where a visible colour change are 
represented by a “+”and no colour change by a “-“. The names of the control samples are accompanied 
by an asterisk (*). 
 
Table 4.3: Qualitative results for yeast sssays of concentrated reactor samples 
	  
4.2.3) Planktonic Cell Release and the Presence of Carbon Sources 
 
Effluent cell numbers were obtained every 24 hours for a 4 day incubation period (Figure 4.11). Figure 
4.12 shows the planktonic cell numbers obtained from each of the 4 collection points of the reactor during 
the steady-state of the biofilms. This state was characterised by maximum and consistent planktonic cell 
numbers released from the biofilm into the bulk flow. 
 
Sample GMP MP GCBZ CBZ 
Compound Methylparaben Methylparaben Carbamazepine Carbamazepine 
Removal 
Efficiency 
Mean 
(%)  59.89 59.32   10.37 -2.58   
Influent (ng.L-1) Std Error 1.38 4.6 0.83 0.83 
Effluent (ng.L-1) Std Error 1.14   2.25  0.15 2.03 
Sample Name  Concentration Sample Name  Concentration 10X 5X 2.5X 10X 5X 2.5X 
Glucose & MP #1 Rep 1 - - - Glucose & CBZ #1 Rep 1 - - - Rep 2 - - - Rep 2 - - - 
Glucose & MP #2 Rep 1 - - - Glucose & CBZ #2 Rep 1 - - - Rep 2 - - - Rep 2 - - - 
MP #1 Rep 1 - - - CBZ #1 Rep 1 - - - Rep 2 - - - Rep 2 - - - 
MP #2 
Rep 1 - - - 
CBZ #2 
Rep 1 - - - 
Rep 2 - - - Rep 2 - - - 
Glucose & MP 
Medium 
Rep 1 - - - Glucose & CBZ 
Medium 
Rep 1 - - - 
Rep 2 - - - Rep 2 - - - 
MP Medium Rep 1 - - - CBZ Medium Rep 1 - - - Rep 2 - - - Rep 2 - - - 
MP 100 g.L-1 * Rep 1 - - + CBZ  g.L-1  * Rep 1 - - - Rep 2 - - + Rep 2 - - - 
MP 100 ug.L-1  * Rep 1 - - - CBZ 100 ug.L-1  * Rep 1 - - - Rep 2 - - - Rep 2 - - - 
MP 10 ug.L-1  * Rep 1 - - - CBZ 10 ug.L-1  * Rep 1 - - - Rep 2 - - - Rep 2 - - - 
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Figure 4.11: Planktonic cell numbers from the flow cell reactor for the duration of the incubation period 
The graph shows the logarithm of culturable cell concentrations over a 4-day incubation period. The standard 
errors were calculated using the standard deviation of the 4 replicates for the logarithm of the cell	  concentration.	  
Figure 4.12: Planktonic cell numbers from the collection points within the reactor 
The graph shows the logarithm of culturable cell concentrations over the 4-day incubation period. The standard 
errors were calculated using the standard deviation of the 4 replicates for the logarithm of the cell concentration. 
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Chapter 5: Discussion 
 
Water is one of the most important, if not the most important, resources supporting life on Earth. Human 
behaviour over the last few centuries has polluted and sullied this key resource. Water is regarded as a 
renewable resource, provided we can remove these pollutants to detoxify the water. However, considering the 
degree to which it has been polluted, the renewal or recycling thereof may not be as simple as originally 
thought. The remediation of water is going to be an essential key to our continued survival on this planet. The 
natural environment has always evolved ingenious ways of maintaining homeostasis after disturbances to an 
equilibrium and, now that our water resource is reaching a critical state (in terms of both quantity and quality), 
it is pertinent that humans look to nature for solutions to a problem we have not yet adequately solved.  
	  
This research was conducted against this background; firstly, to consider what the potential effect of polluting 
compounds are on higher organisms, and secondly, the interaction between these compounds and 
microorganisms, the latter of which, through their metabolic processes, ultimately are of major importance in 
the removal of these compounds from our water sources.  Two prominent micropollutants, namely 
methylparaben and carbamazepine, were selected and their potential effect on human endocrine functionality 
was investigated. The estrogenic effect of methylparaben on the human estrogen receptor was evaluated, 
which has been shown in the literature(Lemini et al., 2003, Błędzka et al., 2014, Wróbel and Gregoraszczuk, 
2014) and that of carbamazepine for its inhibitory effects on the human androgen receptor, which were seen 
in men undergoing anti-epileptic therapy (Reis et al., 2013). Therefore, there was evidence of endocrine 
disrupting potential of these compounds, but the intention of the experimentation in this research was to not 
only confirm these effects, but to ascertain the effects of these two compounds on microbes, both in batch 
culture (planktonic cells) and in biofilms (adhered/ sessile cells). 
 
This project was part of an initiative to further the concept of Biomimicry in South Africa. While the 
biomimicry-inspired Eco-Machine™ at Langrug was not installed in time for analysis in this research, the 
focus was nevertheless on a key component of Eco-Machines, namely microbial metabolism and this potential 
in biomimetic constructs for wastewater treatment. The data is thus presented and considered within the 
framework of Biomimicry.    
 
5.1) The Effect of Micropollutants on Microbial Cultures 
 
Methylparaben was the first compound investigated in this study. Its inhibitory effects on microbial cultures 
were established through both MIC and recombinant yeast assays. The MIC assay tested the effects of a 
concentration range of methylparaben (74.5 ng.L-1 to 10 g.L-1) on the growth potential of both a pure 
bacterial culture (CT07) and a mixed microbial culture. The estimated MIC for the mixed culture (256.27 
g.L-1) was much higher than that for CT07 (10.6 g.L-1). The curve for the mixed culture MIC (Figure 4.1) 
shows fluctuations of the optical density around the maximum optical density, while the curve for CT07 
showed a more consistent line. The reason for the fluctuations was most likely due to the presence of multiple 
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microbial species in the mixed culture. The varying concentrations of methylparaben potentially selected for 
the organisms that could survive and grow in the presence of methylparaben at the particular concentration 
in the well. The MIC curve for the mixed culture did not show a decrease like that which was seen for CT07. 
This was very likely due to the source of the culture: a WWTP through which methylparaben was degraded. 
The large number of different microbial species present ensured at least one or two of those organisms 
capable of tolerating methylparaben survived in the wells at which high concentrations of methylparaben 
were present, resulting in some degree of growth (and therefore a lower than maximum, but measurable, 
optical density). An improvement to the experimental method would have been to repeat these assays with 
a higher maximum methylparaben concentration in order to accurately determine the true MIC, instead of 
mathematically estimating the MIC (since a concentration of 256 g.L-1 should not be possible to obtain with 
methylparaben in an aqueous solution). The remarkable difference in these MIC values between the two 
cultures shows the large degree of resilience that mixed microbial cultures have against antimicrobial 
preservative compounds such as methylparaben.  
 
There were notable differences in the optical density reached by the two cultures in the 20-hour incubation 
period: 1.06 for CT07 and 0.42 for the mixed microbial culture. These differences in optical density can be 
explained by the presence of different microbial species in the mixed culture, compared to only one species 
in the CT07 culture. The generation time for bacterial species is generally much shorter than that of yeasts 
and other fungi. The presence of yeasts and fungi (confirmed presence in the culture through viewing under 
the microscope), as well as other microbes with varying generation times within the mixed microbial culture, 
probably increased the time taken for the culture to reach stationary phase, meaning the optical density 
would have taken a greater amount of time to reach the same optical density that CT07 culture did overnight. 
 
The effect of methylparaben on recombinant yeast was also determined using a yeast estrogen assay. The 
purpose of this assay was two-fold: it determined the lethal dose of methylparaben for yeast, as well as to 
determine the degree of estrogenicity of methylparaben on the human estrogen receptors that were expressed 
by the yeast recombinant. Methylparaben showed no estrogenicity up to 19.5 mg.L-1, after which there was 
an exponential increase in estrogenicity until 316 mg.L-1 after which there was a rapid decrease in measured 
response. This decrease was indicative of  a cytotoxic effect and the cytotoxic effects occurred before the 
complete saturation of estrogen receptor binding by methylparaben (maximum estrogenicity). In other 
words, the yeast cells were killed by the high doses of methylparaben but that the agonistic effects on the 
estrogen receptor would have continued to increase if the cytotoxic effects did not exist, such as would occur 
in mammalian (especially human) cells, to which the estrogen receptor is native. The data means that 
methylparaben is estrogenic, albeit to a low degree (>19.5 mg.L-1), and that it is also cytotoxic to yeast. This 
is congruent with the literature review, where it was explained that methylparaben is used as an antimicrobial 
preservative in products, especially against fungi (yeasts) (Błędzka et al., 2014) and also that estrogen 
receptor agonism has been recorded in cancer cell lines that express estrogen receptors (Wróbel and 
Gregoraszczuk, 2014). The low degree of cytotoxicity of methylparaben against the yeast cells means that 
methylparaben must be included at concentrations equal to, or higher than, the lethal concentration, in order 
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to function as an adequate antimicrobial preservative in personal-care products. This is congruent with the 
literature review, were the concentration of methylparaben in most cosmetic (personal-care) products is 
around 0.3 – 0.4% (Soni et al., 2002, SCCP, 2008)(or 3 – 4 g.L-1). Based on the data, this concentration is 
sufficient to induce estrogen receptor agonism in humans. Therefore, the concentrations at which 
methylparaben is included in products could also induce endocrine disrupting effects in humans, especially 
in products that are applied directly to the skin (and not washed off) and products that are inhaled or ingested. 
In the study conducted in 2014 by Wróbel and Gregoraszczuk, concentrations of methylparaben above 3.04 
µg.L-1 (20 nM) could induce agonism of estrogen receptors in breast cancer cell lines (more sensitive to 
estrogen due to increased receptors in these cells). Relevant products contain upwards of 4 g.L-1 (26.3 mM) 
methylparaben and tissue concentration of methylparaben need only reach 3.04 µg.L-1  (20 nM) for 
estrogenic effects to occur in breast cells. Therefore, it is possible that products like antiperspirants and body 
lotions, applied in close proximity to breast tissue, can be absorbed into breast tissue. This could possibly 
promote, or perhaps even initiate, estrogen-induced breast cancer especially in long term use of 
methylparaben (and other paraben) -containing products. The relevance of this data to water treatment, lies 
in the degree to which parabens are used (and released into wastewater) and the degree of removal that 
occurs in the WWTP. According to the data in the literature review, methylparaben is removed at an efficacy 
of greater than 90% (Kasprzyk-Hordern et al., 2009, Archer et al., 2017) and while that seems adequate, the 
potential for accumulation of parabens exists. The residual parabens will be present in recycled water, and 
the continuous use of paraben-containing products, especially wash-off products, may result in a slow 
accumulation concentrations of parabens in surface water (into which WWTP effluent is dispensed). 
 
Carbamazepine, the second compound that was investigated in this study, was also evaluated for its potential 
effects on microbial cultures. The data in Figure 4.2 show the effects of increasing carbamazepine 
concentrations on the growth (optical density) of both CT07 and mixed microbial cultures. No MIC for 
carbamazepine could be determined as it exhibited no inhibitory effects on either of the cultures. In addition, 
it appeared (from the data in Figure 4.2) that the optical density increases at the highest tested concentrations 
of carbamazepine, in both cultures. This data implies that the increased concentration of carbamazepine 
enhanced growth of the microbes. The other, more likely explanation is that the increased concentrations of 
carbamazepine resulted in supersaturation of the solution, resulting in excess carbamazepine precipitating 
out of the solution. This could have proportionally increased the optical density with increased 
carbamazepine concentrations, which resulted in the apparent proportional increase in optical density that 
was seen in Figure 4.2. The latter explanation is more likely, based on the low solubility of carbamazepine 
in water (O'Neil, 2001), approximately 17.7 mg.L-1 at 25oC (DrugBank, 2005). This implies that the apparent 
lack of growth inhibition seen in the data could have actually been the result of a low, consistent 
concentration of carbamazepine in all the concentrations where more carbamazepine was added than was 
able to dissolve (saturation of the solution). This implies that carbamazepine, if it is toxic to microbes at 
higher concentrations, would not be able to adequately dissolve in an aqueous solution to elicit any inhibitory 
effects, and therefore the MIC of carbamazepine cannot be determined in a water-based solution. It is also 
possible that carbamazepine has no inhibitory effects on microbes, based on its structure and function: 
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carbamazepine is a neurotropic pharmaceutical compound that mimics neurotransmitters found in 
mammalian systems. Therefore, it is possible that carbamazepine has no inhibitory effect because microbes 
have no nervous system and therefore a molecular target may not actually exist in single-celled organisms. 
An MIC could perhaps be established for microbes that are able to grow in an oil-based solution where 
carbamazepine, a highly lipophilic compound, can dissolve with a higher maximum solubility. The same 
fluctuations in optical density were seen in the mixed culture with carbamazepine as was seen with 
methylparaben. The explanation for these findings is the same for carbamazepine as it was for 
methylparaben. This test was not useless, however, since the concentrations that carbamazepine is found in 
water would be below this solubility level. However, the presence of solvents, soaps and other dispersing 
agents (emulsifiers) in wastewater may increase its solubility in water. 
 
The endocrine-disrupting effects of carbamazepine were also investigated. There have been findings that 
showed potential anti-androgenic effects in male humans (Reis et al., 2013). Despite these findings, the 
assay was conducted in this research in order to confirm these effects, and the concentration range at which 
these effects begin to occur and whether the effects occur at levels lower than the therapeutic dose. The latter 
is especially significant when referring to levels that occur in water being dispensed into environmental 
surface water by the WWTPs. The data from these anti-androgenic assays (Figure 4.4) showed that 
carbamazepine did exhibit inhibition of the binding of DHT to the androgen receptor. The anti-androgenic 
effects occurred at carbamazepine concentrations upwards of 776 µg.L-1. Therefore, while carbamazepine 
has a low potency, it still has the potential to interact with the binding of androgens to the androgen receptor, 
thereby interfering with normal hormonal processes. Carbamazepine, sold under various proprietary names, 
is usually administered to patients at daily doses of 100 – 200 mg (DrugBank, 2005), depending on the 
manufacturer. It has been stated previously that 28% of the total plasma concentration is not metabolised by 
the body and is excreted as the active parent compound. This 28% then ends up in the WWTP which removes 
this compound with low efficacy. The degree of removal ranges from 20% to low negative values (Kasprzyk-
Hordern et al., 2009, Archer et al., 2017), which implies that carbamazepine concentrations undergo an 
apparent increase as the compound travels through the WWTP, possibly through re-assembling of 
metabolites by microbial activity. Carbamazepine is mainly used for epilepsy, therefore the use of this drug 
cannot be discontinued, as epilepsy is a serious medical condition. As a consequence, the use of 
carbamazepine will be prevalent in the years to come. Considering the low degree of removal (and increase 
in concentration in some cases) in WWTPs, it has the potential to persist in the meagre 1% of the total 
surface water available for use, with no currently available effective means with which to remove it. If this 
is considered, along with the large degree of interactions carbamazepine has with other drugs (discussed in 
detail in the literature review), the potential for non-target effects on both animals and humans exists. This 
may not be a current concern, since the levels at which carbamazepine is present in WWTP effluent is still 
only at the nanogram per litre level, but if accumulation of the compound is a possibility then the levels may 
rise, over time, to be conducive for pharmacological effects in non-target individuals. The effects of 
carbamazepine on normal hormonal processes in the body, such as the anti-androgenic effects already 
mentioned, could also be a potential risk resulting from accumulation of the compound in water systems.  
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The reactor samples, concentrated during solid-phase extraction for LCMS analysis, that were subject to 
recombinant yeast screens did not show any qualitative effects on the recombinant yeast (Table 4.2). This 
was not surprising, considering that endocrine-disrupting effects occur at concentrations above 19.5 mg.L-1 
for methylparaben and 776 ug.L-1 for carbamazepine, and the concentration of these compounds in the 
samples were lower than this threshold. The assay was conducted in order to confirm the lack of endocrine-
disrupting effects in environmental samples. This implies that environmental concentrations of 
methylparaben and carbamazepine should not elicit any endocrine-disrupting effects, but some mammalian 
cells may be more sensitive to these effects than the recombinant yeast (such as was seen in the research 
conducted by Wróbel and Gregoraszczuk in 2014). Lack of colour change in these samples does not mean 
they are definitely safe, as there may be other physiological factors, involved in the endocrine-disrupting 
potential of these compounds, that may not have been present in yeast cells. However, the results do show 
that there is no direct effect on the estrogen and androgen receptors in the recombinant yeasts. 
 
All the deleterious effects of both of these compounds on mammalian systems, coupled with their inadequate 
removal by conventional WWTPs, highlights the significance of finding more effective strategies to be 
implemented in wastewater treatment. 
 
5.2) The Effect of Micropollutants on Microbial Biofilms 
 
Although the MIC experiments showed minimal effects on the microbial cultures (in the case of 
carbamazepine), or effects at high concentrations only (in the case of methylparaben), the effects of these 
compounds on microbial biofilms were investigated. This was conducted in order to determine if 
environmental levels of these two compounds have any effect on the structure of the biofilms to which they 
are exposed. This was achieved by the use of the flow cell reactor. The extended length of the reactor allowed 
increased temporal exposure of either one or two different energy sources (carbon sources) (either the 
micropollutant and/or glucose) to the biofilm. The motivation behind the extended length was that the 
biofilms upstream would use up the primary carbon source (glucose) first, leaving only the secondary carbon 
source (micropollutant) behind and that the biofilms would use the micropollutant due to lack of another 
suitable energy source. The increased length also increased the time to which the micropollutants were 
exposed to the biofilms, allowing increased opportunity to metabolise the micropollutants, if any catabolic 
potential existed in the biofilm. The inclusion of glucose was to determine if catabolite repression, or a 
mechanism similar in function, would have had an inhibitory effect on metabolism of the micropollutant 
added together with glucose. The premise was that the microbes would metabolise glucose first, due to the 
high energy (ATP) output compared to the energy required to express the enzymes required for catabolism 
(higher net ATP yields). The pathways that the microbes would require to metabolise the micropollutant 
were assumed to be lower in net ATP yields than the metabolism of glucose, therefore presence of glucose 
would result in a decrease in metabolism of the micropollutant compared to the degree of metabolism of the 
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micropollutant alone. This hypothesis, and the hypothesis that environmental levels of micropollutants 
would be sufficient to alter the structure of biofilms, were both tested using the reactor. 
 
The differences in biofilm structure were evaluated using a COMSTAT script in MATLAB®, where image 
stacks obtained with CLSM were converted into qualitative data. The data is shown in Table 4.1. The 
concentration of methylparaben included in the medium (1 µg.L-1) was found to be sufficient to cause 
measurable changes in various structural aspects of the biofilm. Where methylparaben was included with 
glucose in the medium, the biofilms showed statistically significant increases in roughness coefficient and 
surface-area-to-biovolume ratio and a statistically significant decrease in percentage of substratum coverage, 
i.e. biofilm footprint area (Figure 4.7). The decreased substratum coverage can also be seen in the 
comparison of Figure 4.9A and 4.9C. The thicknesses of the biofilm (both average and maximum) were 
increased with the addition of methylparaben into the medium, although the differences were not large 
enough to be considered statistically significant (Figure 4.7 and Table 4.1) with a P value of 0.05. The 
increased thickness could have been due to the presence of an additional source of energy and carbon, and 
that more cells were present as a result. The depletion of methylparaben in the reactor does suggest that the 
cells were capable of metabolising it, and perhaps the microbes utilised an inherent esterase to utilise the 
oxygen and the methyl group (Martinez-Martinez et al., 2014). This significant depletion of methylparaben 
(59.89% with glucose and 59.32% without; Table 4.2) implies that the partial metabolism of methylparaben 
allowed for an increased source of carbon and energy that would explain the increased thickness of the GMP 
biofilms compared to glucose alone. However, this explanation was not consistent with the planktonic cell 
numbers that were obtained from the GMP samples in the reactor (Figure 4.11), since the numbers were 
lower than that of glucose only, and the degree of glucose depletion shown in Figure 4.10 was almost the 
same with GMP, GCBZ and glucose only. Therefore, the logical explanation would be that the amount of 
biomass was increased, but that it was due to more deposits of EPS and not an increase in cell numbers. The 
cause is not known, but it is possible that the presence of methylparaben promotes increased expression of 
EPS components, in an attempt to increase protection of the cells. Methylparaben was suggested to act on 
cell osmoregulation (Nguyen et al., 2014) and therefore an increase in the production of EPS may have 
served to protect the cells from these osmoregulatory effects. The cause of the decreased substratum 
coverage percentage is not certain, but it could possibly have been caused by the adsorption of 
methylparaben to the glass surface, which may have reduced the amount of surface area available for 
interaction with pili for surface attachment. Adsorption results in the binding of molecules to a surface 
(Brown et al., 2006), which creates a film over the aforementioned surface. Methylparaben is slightly polar 
and lipophilic, thus the adsorption of the paraben molecules to the glass during bacterial adhesion may have 
caused decreased surface coverage by bacterial cells due to the reduction of physical space. Another 
explanation may be that an increased need for interaction between species to metabolise the more complex 
molecule was required, which could have caused increased cell clustering and formation of more distinct 
micro-colonies with EPS-filled spaces between them. The biofilms were thicker downstream than upstream 
in the GMP and glucose only. The reason for this is not known as, logically, the depletion of nutrients in the 
reactor should have resulted in less potential for growth downstream, and a thinner biofilm as a result. It is 
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possible that the planktonic cells, released from the upstream parts of the biofilm, become stressed at the 
low levels of nutrients in the downstream parts of the biofilm and revert to a sessile stage and adhere to the 
biofilm, also with the development of protrusions into the bulk liquid phase to increase the surface area for 
nutrient capture. This would cause an increase in biofilm thickness without a drop in total planktonic cells 
released. Figure 4.12 shows that planktonic cell numbers from the second, third and fourth collection points 
were not increased, since the cell numbers between the three points were more or less the same. It would be 
expected that the cell numbers would increase as the bulk flow travels further down the reactor, since the 
amount of cells released should be cumulative. However, there was no significant drop or increase in cell 
numbers in the biofilms between the three last collection points. There was a small decrease between the 
cells numbers obtained from point #1 and point #2 (Figure 4.12), and this could be where cells reverted to 
the sessile stage and joined the biofilm. The lack of significant increase or decrease in cell numbers in the 
biofilm implies a net zero effect between planktonic cell release (detachment) and reversion of sessility 
(reattachment). It is likely the cells were released in similar numbers to those that were added back into the 
biofilm in the more downstream parts of the reactor, causing an apparent lack of the expected increase in 
release of planktonic cells. This shows the remarkable responsiveness of biofilm communities to their 
physical environment (the nutrients contained within the bulk flow, in this case), where cells are constantly 
released into the environment in order to ensure survival and/or proliferation of the biofilm (Bester et al., 
2009). 
 
The samples in which both glucose and carbamazepine were present (GCBZ), compared to glucose alone 
(GLC), also showed statistically significant differences in various structural parameters of the biofilm. These 
differences were more pronounced than in the GMP samples. The average thickness of GCBZ biofilms was 
higher than glucose alone only in the upstream flow cells (Figure 4.7), while the GCBZ biofilms were thinner 
than glucose alone in the downstream flow cell. This decrease in thickness was statistically significant (Table 
4.1). However, the maximum thicknesses of both upstream and downstream GCBZ biofilms were 
significantly thicker than the upstream and downstream biofilms for glucose only (GLC). The downstream 
flow cell biofilms that were exposed to both glucose and carbamazepine were thinner, on average, than the 
downstream flow cell with glucose only but the maximum thickness was larger than glucose only. This 
implies that the biofilms with both glucose and carbamazepine were more varied in surface topography, as 
in the surface was more convoluted, but that the overall thickness was lower than in the GLC samples. The 
roughness coefficient of the GCBZ downstream biofilm was consistent with this statement, as it was larger 
in the GCBZ downstream samples, and the larger the roughness coefficient the greater the variation in height 
of the surface of the biofilm (Heydorn et al., 2000). The amount of biomass also reflects this, as it is 
significantly lower than the biofilm exposed to glucose alone (Figure 4.7). The substratum (surface of the 
glass) coverage for the GCBZ samples was lower in both upstream and downstream flow cells compared to 
GLC and GMP samples. This is seen most significantly in Figure 4.9F.  The cause of this was most likely 
due to the adsorption of carbamazepine to the glass, as carbamazepine is very lipophilic, and has a low 
solubility in water (O'Neil, 2001, DrugBank, 2005) more lipophilic than methylparaben, which may have 
resulted in the larger degree of adsorption of the molecules to the glass surface. Adsorption may have created 
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a film that prevented attachment of the microbial cells to a larger percentage of the glass flow cell surface 
than with GMP or GLC samples. Another explanation is that the increased need for cometabolism caused 
clustering of cells, reducing the surface area covered. The reason for the lower biomass and thickness of 
GCBZ downstream compared to upstream is likely due to the depletion of glucose through the reactor, which 
resulted in less potential for cell growth and EPS production in the downstream portion of the reactor. This 
was also suggested for the GLC and GMP samples, but the lack of increased average biofilm thickness 
implies that the cells did not reattach to the biofilm, as was suggested in the former two sample types. The 
lack of increased biomass (Figure 4.7), the significantly increased maximum thickness (Figure 4.7) and the 
lack of increased cell counts (Figure 4.12) would suggest that the cells reattached to the biofilm but that the 
reattachment occurred in only specific, limited parts of the biofilm, such as in discrete micro-colonies. This 
would explain the significant increased variation in the surface topography of the biofilm, but the lack of 
increased biomass or cell counts. The cause for limited spatial adhesion in the biofilm could very likely have 
been due adsorption of carbamazepine onto the biofilm and the adsorption onto the glass surface at the 
attachment stage of incubation, mentioned earlier. Adsorption of carbamazepine has been reported to occur 
to a degree, although not extensively, in agricultural soils (Calisto and Esteves, 2012), and therefore it is 
possible that adsorption was responsible for the findings described above. The other explanation is that the 
cells aggregated into these longer, protruding cell clusters in order to aid increased capture of nutrients from 
the bulk flow (essentially increasing the surface area exposed to the bulk flow) in response to the depletion 
of nutrients. This is consistent with the increase in roughness coefficient seen with the GCBZ downstream 
compared to upstream. 
 
The carbamazepine was not used as a carbon or energy source, based on the LCMS data where 
carbamazepine levels actually increased while the bulk flow travelled through the reactor (effluent levels 
are higher than influent levels). The influent levels for both GBZ and CBZ samples were the same, but the 
effluent carbamazepine levels were increased in both samples of effluent: -10.37% in GCBZ and -2.58% in 
CBZ. This is consistent with what was stated in the literature review, where carbamazepine increases in 
concentration during water treatment in some cases (Kasprzyk-Hordern et al. 2009), although it can be 
expected that the breakdown products that contribute to reconstitution in wastewater were absent in this 
study. However, it is possible that carbamazepine molecules within the medium flasks broke down, through 
an unknown mechanism, during the incubation period which would cause a lower than expected 
concentration in the influent. This would, in turn, cause an apparent increase in carbamazepine in the effluent 
if these metabolites were to be reconstituted back into carbamazepine within the reactor. The removal 
efficiencies of the two micropollutants were not significantly influenced by the presence of glucose (Table 
4.2) but the presence of glucose seems to have increased the degree to which carbamazepine accumulated 
in the reactor (degree of increased carbamazepine was larger in GCBZ than in CBZ). The statistical analysis 
of the mass spectrometry results (Table 4.2) suggests that the results are reliable and have low errors, but 
there were not enough replicates. Four samples were taken for the influent and effluent of each 
micropollutant (both with and without glucose) but the mass spectrometer used was very sensitive 
(maximum of 0.9 g.L-1) and the machine was communal. It was possible that previous users had not regarded 
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this maximum concentration limit because some of the readings showed large amounts of micropollutants 
in the blanks (HPLC-grade methanol only), which only occurs when carry-over from one sample to the next 
takes place during the sample reading in the mass-spectrometer. There were also compounds present in the 
samples that were not added. Since reverse osmosis water was used, the presence of these contaminating 
compounds was likely from carry-over in the machine, or from residual compounds in the laboratory 
glassware. The presence of micropollutants of interest (methylparaben and carbamazepine) in the blanks 
reduced the reliability of the quantitative influent and effluent concentration data, and this was why only the 
relative change in concentration was reported. Since the influent and effluent concentrations were measured 
using the same analysis, they could still be used to calculate the relative change in concentration, but not to 
report actual concentration in the medium. Due to the difficulty encountered with standardising the LCMS 
data, only two samples per GMP, MP, GCBZ and CBZ were presented in this research. This is not a 
sufficient number of replicates to ensure that the results were precise, therefore an improvement would have 
been to increase the number of samples and submissions. This was not possible in the scope of this research, 
because of budget constraints. Therefore, a standard protocol and mass spectrometry methods should be 
established so that any and all possible experimental errors could be removed to avoid wasting time and 
money on repeated LCMS sample extractions and submissions. There was not sufficient time to do this 
within the scope of this research. 
 
The samples in which methylparaben (MP) or carbamazepine (CBZ) was added, showed significant 
differences in the topography and aggregation of the biofilms. The maximum thicknesses of the biofilms in 
the MP samples was significantly larger than those in the CBZ samples, in the upstream flow cells, and 
larger to a lesser degree in the downstream flow cells. However, these differences were both statistically 
significant in the ANOVA/T-Test calculations with a P value of 0.05. The reason why the methylparaben-
exposed biofilms were significantly thicker than carbamazepine-exposed biofilms was likely due to partial 
catabolism of the compound via the inherent esterases, mentioned earlier, which would result in the release 
of methyl alcohol (methanol). The result of the hydrolysis may have yielded energy for increased metabolic 
activity, either growth of cells or increased EPS production. The other possibility is that the methanol 
released during esterification could have been a source of carbon and energy. Although methanol is toxic 
(Skrzydlewska, 2003), it can be assimilated by bacteria, such as Alpha Protetobacteria (Radajewski et al., 
2000; Madsen, 2008), which may have been present in the biofilm. The LCMS data showed that 
methylparaben was degraded (metabolised) to an extent (about 60%, Table. 4.2) and if it was assimilated, 
then this would explain why the thickness was increased in the MP samples than it was in the CBZ samples. 
The roughness coefficient was larger overall in the CBZ samples than the MP samples.  
 
Based on the findings of this research it is evident that micropollutants do affect the structure of the biofilms 
to which they are exposed, thereby achieving the first aim of this research. The hypothesis that small 
concentrations of micropollutants (1000 ng.L-1 for methylparaben and 600 ng.L-1 for carbamazepine) would 
have an effect on biofilm structure was therefore not rejected. It is still unsettling, however, that 
concentrations at the microgram and nanogram per litre level can affect bacterial biofilms to a measurable 
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degree. These findings bring to the fore that micropollutants, even at infinitesimal concentrations, may have 
a more pronounced effect on bacterial biofilms than would have been thought possible. 
 
5.3) Potential of Biomimetic Concepts for Adequate Micropollutant Removal 
 
Biomimicry is not a new concept, but it is being more widely accepted as a means to use inspiration from 
nature to solve anthropogenic problems. Based on the incomplete removal of micropollutants by 
conventional WWTPs already discussed in this research, another, more effective, method is required if 
micropollutants are to be removed with a larger degree of efficacy. It is possible that biomimicry may 
provide the means with which to acquire the solution to incomplete micropollutant removal.  
 
The potential of biomimetic designs in the treatment of wastewater, and greater removal efficiency of 
micropollutants, may lie in the nature of microorganisms themselves. While biomimetic constructs, such as 
Eco-Machines™ and constructed wetlands, mimic a natural system, they make use of existing organisms 
and their metabolic capabilities. It has been argued that the use of microbes to solve wastewater problems is 
not biomimicry, but is rather classified as bio-assistance and bio-utilisation. These definitions essentially 
prevent the use of these organisms in novel systems, if the status of “biomimicry” is to be achieved. 
Therefore, the two processes of bio-assistance and bio-utilisation should be considered part of the 
biomimetic design process, allowing the consideration of microbes as agents to biomimetic designs.  
 
Microbial biofilms, from the findings in the previous sections, follow many of the guidelines included in the 
“lifes’ principles” paradigm (Figure 2.5), used in the design of biomimetic constructs, further contributing 
to the merit of using microbes in biomimetic designs. It was suggested that planktonic cells, released by the 
more upstream part of the biofilm, reattach to the downstream biofilm in response to the drop in nutrient 
concentration. Biofilms (a sessile living state) offer a situation more conducive to low nutrient density, since 
the cells can revert to cometabolism (living with other microbes) or even enter a state of dormancy until an 
environmental change occurs that is more suitable for growth (increased nutrient density). This adaptation 
to changing conditions, through environmental cues, is one of the key aspects of “lifes’ principles”. The 
planktonic cells “integrate the unexpected” and “adapt to changing conditions” (Figure 2.5), by reverting to 
a sessile living state when nutrients are lacking. The biofilm creates an environment where microbes can 
utilise resources efficiently (“be resource efficient”, Figure 2.5), through cometabolism or through 
dormancy. The change in biofilm thickness in the presence of micropollutants, especially with 
methylparaben, would suggest that the microbes within the biofilm use the micropollutants to build up 
biomass, whether they use the compound (or its metabolite) as a building block or they produce more EPS 
in its’ presence. Either way, the presence of micropollutants, even at low concentrations, can trigger 
responses in the biofilm. Metabolism of methylparaben (seen in the research) is an example of how microbes 
can adapt to metabolising compounds that may not be natural (synthetic) or that the biofilm would not 
ordinarily be exposed to. This shows how biofilms can elegantly execute “lifes’ principles” to “use readily 
available materials and energy” (Figure 2.5). The change in overall structure of the biofilm in the presence 
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of micropollutants, such as the formation of discrete microcolonies and significant changes in the topography 
(roughness coefficient and surface area to biovolume changes), also shows how microbial biofilms can 
change structure in response to their immediate environment. This complies with the principles of self-
organisation and the incorporation of diversity (Figure 2.5) in order to optimally use the resources that are 
available, for survival and proliferation. 
 
The above examples, linking the principles of biomimetic design to biofilms, illustrate just how much 
microbial biofilms adhere to “lifes’ principles” (which they would, since they are directly from nature) and 
therefore would be prime candidates to explore in solving wastewater treatment challenges. Perhaps 
harnessing the abilities of microbes, taken from nature, and manipulating these abilities to solve wastewater 
treatment challenges is not entirely biomimetic (according to anthropogenically-assigned definitions). 
However, the fact that microbial biofilms closely follow the principles of biomimetic design shows how 
valuable they can be in wastewater treatment, especially considering their functions cannot yet be emulated 
by humans. 
 
Other biomimetic constructs, such as constructed wetlands, have been shown to remove certain recalcitrant 
compounds, such as carbamazepine (Hijosa-Valsero et al., 2010a), with greater efficiency than conventional 
WWTPs, further emphasising the potential of biomimetic design for improved wastewater treatment and 
micropollutant removal. Based on the findings from the literature, coupled with the ability of microbial 
biofilms to adhere to the principles of biomimetic design and the fact that other biomimetic constructs (which 
make use of biofilms) have been shown to exhibit improved micropollutant removal shows that biomimicry 
is indeed a viable option in improved removal of micropollutants from wastewater. The fact that biomimetic 
designs make use of existing ideas in nature, also makes biomimetic design a more sustainable and 
potentially more eco-friendly option in the search for more efficient solutions to wastewater treatment. 
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Chapter 6: Conclusions 
 
The remediation and reclamation of water has become a critically important issue. The use of water as a 
conduit of waste has resulted in the contamination of a resource that life on Earth cannot function without. 
Wastewater treatment data show that pollutants are often not being removed, to a degree considered adequate, 
from treated water and, in some cases, micropollutants are found at higher levels in treated water.  
 
The first aim within this study was to determine the effect of a labile carbon source on the degradation of two 
micropollutants. Based on the findings the presence of glucose, a labile carbon source, does seem to have an 
effect on the removal of micropollutants, although under the conditions applied in the experimentation this 
effect was not significant. 
 
The effects of two compounds were investigated in this study: methylparaben and carbamazepine, the former 
is a compound that has a high removal efficiency in existing wastewater treatment plants, while the latter is 
relatively recalcitrant. Methylparaben, as previously mentioned, is a compound widely used as a 
microbiological preservative in personal care products. The concentrations of this compound in wastewater 
effluent in South Africa can be as high as 1 µg.L-1 (Archer et al., 2017). While conventional WWTPs appear 
to remove methylparaben with relative efficacy (100 ng.L-1 in effluent (Archer et al., 2017)), the continued 
presence of these compounds in treated water remains a concern. The MIC of methylparaben (10.6 g.L-1 for 
CT07, and estimated 256.7 g.L-1 for the mixed culture), is alarming considering this compound is used as an 
antimicrobial preservative in personal care products and that the lowest inhibitory concentration to prevent 
growth of microbes is greater than the threshold concentration at which estrogenic effects occur. Considering 
that the final concentration of methylparaben is present in personal care products is between 0.3 and 0.4% 
(Soni et al., 2002, SCCP, 2008),  this compound is included in cosmetics in dose high enough to prevent 
microbial growth, which happens to be the dose required to elicit estrogenic effects. The use of this compound 
in personal care products should therefore be questioned, as the deleterious effects could outweigh the 
benefits. There is evidence that this is already happening in the industry, where the number of “paraben-free” 
products available on the market has increased, and some brands have even removed parabens from their 
ingredient list. 
 
Carbamazepine is an anti-epileptic pharmaceutical compound with a long list of deleterious endocrine effects. 
This compound is also extremely recalcitrant, with levels increasing during the water treatment process. The 
mechanisms behind this apparent increase are, as yet, not fully understood but the increase is alarming 
nonetheless.   
 
The list of potential biologically-active micropollutants is long and the two compounds investigated here 
represent a mere fraction of these. The more these compounds are used and are continuously added into the 
water systems, while not being completely removed, means that these compound will continue to build up, 
albeit slowly, in our water systems. The implication being that these compounds, while perhaps not yet 
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harmful, may eventually reach levels whereby they may elicit deleterious effects in higher organisms, without 
a means with which to adequately remove them.  
 
The second aim of this study was to determine the effects of the chosen micropollutants on the biofilms. The 
effects are arguably significant, considering the very small concentrations they were tested at. The effects that 
these compounds appear to have on the growth and ultimate physical appearance of biofilms is also something 
of a concern because it means these compounds, even at nanogram levels, have a measurable effect on the 
structure, and perhaps the metabolic activities of microorganisms and may, in turn, cause some level of 
deleterious effect on the metabolism of the biofilms. This may, in turn, actually hinder the removal of the 
compound causing the effect, or even of other compounds present in the bulk flow of the exposed biofilms. 
 
Despite the growing body of evidence, there still seems to be inadequate concern for the imminent water 
crisis. In order to secure life on earth in the future, the water sources we have need to be reused and, in order 
to do that, the water needs to be sufficiently cleared of micropollutant contaminants. It appears that 
conventional wastewater treatment is often not sufficient to solve this problem, pointing to the need for 
improvement of existing technologies, or to find alternatives. A renewed recognition of nature’s innovative 
and adaptable ways to address problems that humans could not arrive at themselves, and adoption of nature’s 
solutions, or processes that can be harnessed, manipulated and enhanced, in order to solve pollutant removal 
problems should be encouraged. Using biomimetic principles may provide useful cues. The third aim to 
evaluate the potential of these systems in the treatment of water could not be achieved as the Eco-Machine™ 
has not yet been installed due to delays related to tender processes and government approval, therefore such 
evaluation remains an academic exercise. These systems do show promise, although their lower throughput 
levels should be considered in order to set realistic expectations.  
 
Nature has developed its own solutions to handling problems, some of which are amazingly elegant in their 
simplicity, and perhaps humans need to look to nature for an improved water treatment solution.  After all, 
the simplest solutions are often the most effective. 
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